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ABSTRACT OF THE DISSERTATION 
Genomic Analysis of Diverse Bacterial Pathogens 
for Arts & Sciences Graduate Students 
by 
Robert Potter 
Doctor of Philosophy in Biology and Biomedical Sciences 
 Molecular Microbiology & Microbial Pathogenesis 
Washington University in St. Louis, 2020 
Professor Gautam Dantas, Chair 
Bacterial pathogens have been a historical scourge for the entirety of human 
existence but have been significantly thwarted since the 20th century due to the 
development of antibiotics. However, owing to the large selection pressure of antibiotics 
on bacterial populations, phenotypic antibiotic resistance from the development of 
vertically transmitted mutations and horizontally acquired antibiotic resistance genes 
(ARGs) is increasing. The sum has produced multidrug resistant organisms (MDROs) 
which have extremely limited treatment options. Epidemiological studies have 
determined that carbapenem resistant Enterobacteriaceae (CRE), Acinetobacter 
baumannii, and vancomycin resistant Enterococcus (VRE) are some of the most 
problematic MDRO infections.  
The advent of cost-effective and accurate next-generation sequencing has 
resulted in a proliferation of bacterial genomes available. ARGs, antibiotic resistance 
conferring single nucleotide polymorphism (SNPs), and virulence genes can be 
identified within an assembled genome by comparison to known databases. The 
xi 
 
combination of the genetic information encoded within the genome of an isolate along 
with metadata related to important phenotypes or clinical context can be used to identify 
trends in ARG carriage, evolution over time, and differences in gene burden. This 
information can also be used in understanding the effects of antibiotic treatment on multi 
organism infections such as bacterial vaginosis. 
My thesis intends to investigate features related to natural populations of 
bacterial isolates in the Enterobacteriaceae family and Acinetobacter baumannii in 
Chapters 2, 3, 4 and the Gram-positive organisms Enterococcus faecium, Gardnerella, 
and Corynebacterium in Chapters 5, 6, and 7.  
In Chapter 2 we identify the carbapenem resistance gene blaIMP-27  in a clinical 
isolate of carbapenem resistance Providencia rettgeri. We then acquired two blaIMP-27 
bearing Proteus mirabilis and determine that one isolate (PM187) also has it on a 
plasmid. We were able to completely close the blaIMP-27  bearing plasmids pPR1 and 
pPM187 and determine that the local genetic context was similar but the background of 
the plasmids were different.  In Chapter 3 we collect a cohort of longitudinally antibiotic 
resistant organisms recovered from hospital surfaces in the United States and Pakistan. 
We compare the phenotypic identification with the genomic identification to determine 
that several isolates represent novel taxonomic groups, we identify a severe degree of 
phenotypic antibiotic resistance in the collected important human pathogens and 
elucidate a network of ARGs common amongst the bacteria. Importantly, we 
demonstrate that E. faecium and A. baumannii co-occur greater than predicted by 
chance a lone and that laboratory strains of these organisms are capable of forming 
synergistic growth in biofilms. In Chapter 4 we collect a cohort of Klebsiella variicola 
xii 
 
from Washington University and use whole-genome sequencing to determine the 
population structure of all publicly available K. variicola genomes and identify genes 
relevant for infection related phenotypes. We show that these differences may have a 
functional consequence as some K. variicola strains can be more competent 
uropathogens than Klebsiella pneumoniae. 
In Chapter 5 we compare linezolid resistance mechanisms within a cohort to 
VRE from the United States and Pakistan to determine that all of the US isolates were 
resistant due to SNPs in the 23S rRNA sequence, but the Pakistan isolates all had 
acquired ARGs. Two of these ARGs were the limited scope efflux pumps optrA and 
poxtA but the other ARGs are novel variants of the cfr family. In Chapter 6 we analyze a 
set of publicly available Gardnerella vaginalis genomes and metatranscriptomes of 
women with bacterial vaginosis to determine that what is commonly considered a single 
species can be interpreted as 9 different species with differences in accessory genome 
function and varying presence in bacterial vaginosis cases. Different genomospecies 
are present at varying abundance and putative virulence genes have high expression 
values during infection. Finally, in chapter 7 we determine the effects of acquired 
daptomycin resistance on the biology of Corynebacterium striatum. In summation this 
work provides novel insights on the relatedness of important human pathogens to one 





















Chapter 1: Introduction 
1.1 Bacterial pathogens and antibiotic resistance 
 While bacteria are ubiquitous in all studied environments, they are perhaps best 
known for their capacity to cause disease in humans. Evidence of their damaging 
effects on human civilizations have been documented since antiquity but it was not 
until the development of microscopes and the germ theory of disease in the 17th-19th 
century that the culprits of disease were identified(1). With the serendipitous 
discovery of penicillin by Alexander Fleming and the development of arsenic based 
compounds by Paul Ehrlich in the early 20th century humans finally became 
equipped to fight back(2). The combination of knowledge that many diseases were 
bacterial in origin and that small molecules can be developed or identified that could 
selectively kill microorganisms while leaving humans unscathed led to the golden 
age of antibiotic development(2). However, soon after implementation of these new 
drug modalities into clinical use it became apparent that more treatment failures 
were occurring(3). Unfortunately, this increased development of resistance coincided 
with a drop in the development of new antibiotics during the later part of the 20th 
century, leading to the current crisis of global antibiotic resistance threatening one of 
modern medicines greatest achievements(3). 
 Through analysis of bacterial DNA it has been established that bacteria can gain 
antibiotic resistance through alteration of antibiotic targets (ie daptomycin resistance 
in Corynebacterium occurring through loss of phosphatidylglycerol in the cell 
membrane), increased efflux of antibiotics via pumps (ie presence of optrA or poxtA 
in Enterococcus conferring linezolid resistance), modification of the antibiotic 
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(carbapenemases in Enterobacteriaceae and Acinetobacter baumannii able to 
cleave carbapenems), or decreased penetration of the antibiotic due to porin loss 
(multiple bacteria)(3). In 2013 and updated in 2019, the CDC analyzed 
epidemiological trends and the ability of our current arsenal to stave off infection to 
create a list of the most urgent and serious antibiotic resistance threats(3). These 
include carbapenem resistant Enterobacteriaceae, multidrug resistant Acinetobacter 
baumannii, extended spectrum β-lactamase producing Enterobacteriaceae, and 
vancomycin resistant Enterococcus(3). 
 In addition to these clearly delineated threats, there is a need for constant 
surveillance of possible future problems related to antibiotic treatment failure. 
Bacterial vaginosis is a common infectious disease of women that is caused by 
several bacteria including Gardnerella vaginalis(4). Metronidazole is an anerobic 
bacteria targeting antibiotic however in 1/3-1/2 of bacterial vaginosis cases it is not 
capable of clearing the infection, confounding factors the mechanism of resistance 
by G. vaginalis or other vaginal bacteria is not known(4). An additional emerging 
complication is the rapid development of daptomycin resistance in Corynebacterium 
striatum due to loss of function mutations in phosphatidylglycerol synthase leading to 
a depletion of phosphatidylglycerol in the membrane(5). This resistance 
development has been demonstrated to occur in multiple C. striatum isolates and 
overnight(5).  




 Since the development of accurate and cost-effective next-generation 
sequencing technologies there has been an explosion of bacterial genomes 
available(3). Essentially, bacteria DNA can be isolated from purified cultures and used 
as input for sequencing libraries. Currently the most common platform is the second 
generation short read Illumina technology and the longer read PacBio and Oxford 
Nanopore systems(3). Following completion of the sequencing run the reads can be 
processed to remove artificial adapters and low-quality signals. These reads can then 
be assembled into scaffolds or contigs representing the bacterial genome(3). From 
comparison of many different bacterial genomes, we can identify genes relevant for 
virulence or antibiotic resistance by comparison against known databased, construct 
core-genome phylogenies to examine relatedness of isolates and use as input for 
average nucleotide identity analysis to determine if two or more bacterial genomes are 
from the same species(6).  
 Since first identified by Antoine van Leeuwenhoek in the 17th century, bacteria 
isolates have been categorized into species alongside known plants and animals. Given 
the lack of knowledge on DNA at the time, historical species delineation in bacteria was 
accomplished through analysis of phenotypic traits such as enzyme activity(7). It was 
later determined that certain molecules such as fatty acids and respiratory quinolones 
have efficacy in differentiating bacteria from one another. A breakthrough in 
understanding the relatedness of bacteria occurred in the 1980’s when Carl Woese 
determined that the 16S rRNA sequence provides discriminatory resolution for analysis 
of most bacterial genera and some species(7). Since then, incorporation of the bacterial 
genome has been one of the most useful metrics for delineation of bacterial species. In 
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the pre-genomic era this was accomplished using laborious DNA-DNA hybridization 
assays. Currently, average nucleotide identity has become the gold standard for in silico 
differentiation of bacterial species(6). This has resulted in a proliferation of the number 
of new species and a revision of some medically relevant species such as Klebsiella 
pneumonie into Klebsiella variicola and Klebsiella quasipneumonie(8). Currently, it has 
been established that bacterial species may exist as a mono phyletic group with a high 
amount of similarity to one another regarding their core-genome(7). Horizontal gene 
transfer from other taxa may complicate this matter, which is why the increased number 
of bacterial genomes due to advances in sequencing technology provide an ideal way to 
study bacterial species(7) .   
1.3 References  
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Chapter 2: blaIMP-27 on transferable plasmids in Providencia rettgeri and Proteus 
mirabilis 
2.1 Abstract 
A carbapenem resistant Providencia rettgeri (PR1) isolate was recovered from a wound 
infection in Missouri, USA. This isolate possessed an EDTA inhibitable carbapenemase 
that was unidentified using the Xpert CARBA-R assay. Our objective was to elucidate 
the molecular determinant of carbapenem resistance in this isolate. We then sought to 
test the transmissibility of blaIMP-27 loci in clinical P. rettgeri and Proteus mirabilis 
isolates. In October 2016 the novel ambler Class B carbapenemase blaIMP-27, was 
reported in two different Proteus mirablis (PM185 and PM187) isolates. Broth mating 
assays for transfer of carbapenemase activity were performed for the three clinical 
isolates with recipient sodium azide resistant Escherichia coli J53. Antibiotic 
susceptibility and phenotypic carbapenemase activity testing was performed on the 
clinical isolates, J53, and transconjugants using the Kirby-Bauer Disk diffusion method 
according to Clinical & Laboratory Standards Institute guidelines. Plasmid DNA from 
PM187, PR1, and their transconjugants were used as input for Nextera Illumina 
sequencing libraries and sequenced on a NextSeq platform. PR1 was resistant to both 
imipenem and meropenem. PM187 and PR1 could transfer resistance to E. coli via 
7 
 
plasmid conjugation (pPM187 and pPR1). pPM187 had a virB/virD4 type IV secretion 
system (T4SS) whereas pPR1 had traB/traD (T4SS). 2 of 3 blaIMP-27 bearing clinical 
isolates tested could conjugate resistance into E. coli. The resulting transconjugants 
became positive for phenotypic carbapenemase production but did not pass clinical 
resistance breakpoints. blaIMP-27 can be transmitted on different plasmid replicon types 
that rely on distinct classes of T4SS for horizontal transfer.  
2.2 Introduction 
In January 2016, we isolated a carbapenem resistant Providencia rettgeri (PR1) from a 
foot wound infection of a patient who visited an outside hospital affiliate of Barnes-
Jewish Hospital (Missouri, United States). PR1 was positive for an EDTA-inhibited 
carbapenemase but no gene was identified by multiplex PCR. Whole genome 
sequencing (WGS) and antibiotic resistance gene (ARG) identification of the PR1 draft 
genome identified blaIMP-27. blaIMP-27 was first reported in October 2016 from two Proteus 
mirabilis strains (PM185 and PM187) from the upper plains region of the United States 
(1). In December 2016, blaIMP-27 was identified on IncQ plasmids from a variety of swine 
associated Enterobacteriaceae in the United States (2). Given these recent reports, the 
greater Midwest region of the United States may be endemic for blaIMP-27, and a 
potential source for wider geographic dissemination. Accordingly, we acquired PM185 
and PM187 to understand, with PR1, the potential for lateral transfer of this resistance 
gene from P. mirabilis and P. rettgeri into E. coli, and the associated changes in 




2.3.1 Southern blot confirmation of blaIMP-27 in transconjugants 
Southern blot analysis indicates that PR1 has a single copy of blaIMP-27, similar to the 
previous report on PM185 (1). In contrast, the PM187 had two copies of blaIMP-27 (1). 
2.3.2 Conjugation effects on phenotypic resistance in E. coli J53 
PM185 and PM187 were intermediate and susceptible to meropenem and imipenem, 
respectively (Table 1). Only PR1 was resistant to both carbapenems. PM185 was 
indeterminate for the carbapenem inactivation method but PM187 and PR1 were both 
phenotypically positive (Table 1). Transconjugants were obtained from conjugation 
Figure 2.3.1. Depiction of plasmids harboring blaIMP-27 in PM187 and PR1 
(A) Annotated plasmid diagram from DNAPlotter of pPM187 (36,843 bp) displaying 
blaIMP-27 co-localized with a Class II integron gene cassette and type IV secretion 
system. The inner most ring shows GC plot, the second ring shows GC skew, the third 
ring represents open reading frames in the forward direction, and the fourth ring 
(adjacent to the nucleotide position counter) indicates open reading frames in the 
reverse direction.  (B) Annotated plasmid diagram from DNAPlotter of pPR1 (107,365 
bp) displaying blaIMP-27 co-localized with a Class II integron gene cassette, a tra operon, 
and additional resistance genes.  
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assays of PR1 and PM187 with the E. coli J53 recipient but not PM185. Although 
conjugation did not achieve clinical resistance guidelines, the zone size for meropenem 
decreased from 32 mm in J53 to 25 mm in J53: pPM187 and 27 mm in J53:pPR1 
(Table 2.3.1) (27). The zone size for imipenem decreased a lesser amount, from 33 mm 
in J53 to 31 and 32 mm in J53: pPM187 and J53:pPR1, respectively. Both 
transconjugants were positive for phenotypic carbapenem production (Table 2.3.1).  
2.3.3 Complete blaIMP-27 positive plasmids sequence 
The plasmid from PM187, pPM187 (Genbank NOWA01000087.1), contains a putative 
virB/D4 IV secretion system operon, providing a potential mechanism for horizontal 
dissemination (Figure 2.3.2A). The virB4 amino acid sequence had 100% identity over 
its entire length with a conjugal transfer protein (WP_012368868.1) from P. mirabilis 
HI4320 (11). pPM187 has an IncX8 backbone, a newly discovered IncX family member 
(12). Unlike pPM187, the assembled blaIMP-27 bearing plasmid, pPR1 (Genbank 
NOWC01000095.1) did not have a plasmid replicon identified. pPR1 also contained a 
putative type IV secretion system, though of the tra/trb type (Figure 2.3.2B).  The traN 
amino acid sequence had 100% identity across its entire length to the traN 
(WP_023159916.1) of the blaNDM-1 bearing plasmid pPrY2001 from P. rettgeri 
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In this study, we used conjugation experiments to determine that two blaIMP-27 positive 
clinical isolates, PM187 and PR1, could transfer carbapenemase production to E. coli. 
We used Illumina sequencing of the transconjugants and clinical isolates to assemble 
the blaIMP-27 bearing plasmids, pPM187 and pPR1.   
E. coli transconjugants with these plasmids (pPR1 and pPM187) gain detectable 
carbapenemase activity, but this activity does shift the transconjugants to a past clinical 
breakpoints for carbapenem resistance.  It is possible that regulatory or translational 
optimization of the conjugated blaIMP-27 bearing plasmid in E. coli is required for clinical 
resistance (14). In addition to blaIMP-27 expression, it is also possible that porin mutations 
Table 2.3.1. Zone disk diffusion results for wildtype (P. mirabilis PM185, P. mirabilis 
PM187, P. rettgeri PR1, and E. coli J53) and transconjugant (E. coli J53:pPM187 and E. 
coli J53:pPR1) isolates in this study.  
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or efflux activity in the clinical isolates could contribute to phenotypic carbapenem 
resistance (15). 
A previous investigation found that while blaIMP-27 was plasmid-borne in swine-
associated Enterobacteriaceae, the IncQ plasmids were not conjugatable. In contrast, 
the plasmids we have completely sequenced are capable of self-mobilization, likely due 
to a virB/virD4 T4SS in pPM187 and a traB/traA T4SS in pPR1. The virB4 and traN 
gene from these T4SS showed similarity to previously described systems from 
pathogenic P. mirabilis HI4320 and carbapenem resistant P. rettgeri 09ACRGNY2001 
(11,13). A limitation of our approach was that Illumina whole genome sequencing could 
not unambiguously assemble the chromosome and all plasmids in PM187 and PR1.  
Further work is therefore warranted using long reads sequencing technology (e.g., from 
PacBio or Oxford Nanopore sequencing) on blaIMP-27 isolates to unequivocally determine 
chromosomal sequences and compare the nonconjugatable blaIMP-27 IncQ plasmids with 
pPM187 and pPR1. Although southern blot analysis indicates only a single blaIMP-27 loci 
exist in PM185 and PR1, this may further enable a comparison between the 
chromosomal and plasmid (pPM187) platforms of blaIMP-27 in PM187.   
blaIMP-27 was unidentified using the FDA-cleared Xpert CARBA-R assay but the first 
report of blaIMP-27 used the ARM-DTM Multiplex PCR, which indicates some commercially 
available platforms can assay for blaIMP-27 (11). Therefore, further evaluations of 
commercial molecular diagnostic tests for blaIMP-27 is warranted. 
2.5 Materials & Methods 
2.5.1 Bacterial Isolates 
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The Providencia rettgeri isolate (PR1) was recovered from a chronic foot wound 
infection clinical culture. The isolate received for evaluation was a de-identified 
strain. As a result, the study team was not able to obtain patient consent. Proteus 
mirabilis strains (PM185 and PM187) were provided by Nancy Hanson at Creighton 
University (1). The sodium azide resistant E. coli J53 strain (ATCC number BAA-2730™) 
was used as a recipient for transconjugation experiments.  
2.5.2 Broth Conjugation 
Colonies of PM185, PM187, PR1, and wildtype E. coli J53 were separately suspended 
in Tryptic Soy Broth (TSB) (Sigma Aldrich, St. Louis, MO) and diluted to 0.05 OD600. 100 
μl of PM185, PM187, and PR1 were separately added to 100 μl E. coli J53 (for a 1:1 
ratio) and diluted to 5 mL with TSB. Co-cultures were incubated at 37 °C without 
shaking for 24 hours. 50 μl of co-cultures were suspended onto MacConkey agar plates 
containing sodium azide (Thermo Fisher Scientific, Waltham, MA) (150 μg/ml) and 
ceftriaxone (5 μg/ml), spread with glass beads, and incubated for 18 hours at 37 °C. 
Individual transconjugant colonies were propagated overnight in TSB supplemented 
with 5 μg/ml ceftriaxone under shaking conditions (220 rpm). 
2.5.3 Susceptibility Testing 
Each clinical isolate, J53, J53:pPR1, and J53:pPM187 were cultured overnight as 
described previously. E. coli ATCC 25922 was used as a quality control. Susceptibility 
testing was performed using Kirby Bauer Disk Diffusion on Mueller Hinton Agar (Hardy 
Diagnostics) in accordance with CLSI Standards (3).  
2.5.4 Southern blot 
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Total genomic DNA was extracted from PM185, PM187, PR1, J53, J53:pPM187, and 
J53:pPR1 using the Bacteremia kit (Qiagen). Southern blot protocol was used to 
separate the plasmid components from the chromosome and examine localization of 
blaIMP-27 using P-32 labeled primers (21). 
2.5.5 Plasmid assembly and annotation  
We used Illumina sequencing to specifically investigate blaIMP-27 bearing plasmids in 
PR1 and PM187. Plasmid DNA was obtained using a miniprep kit (Qiagen, Valencia, 
CA). Plasmid DNA for PR1 and PM187 was processed to remove Illumina adapters 
(trimmomatic) and contaminating DNA (deconseq). The paired reads were assembled 
into contigs with SPAdes v3.9.0 (4). Raw reads from the transconjugant minipreps were 
processed for quality in a similar manner. 100% of the transconjugant reads that aligned 
back to the clinical isolate plasmid assembly using Bowtie2 were assembled into contigs 
with SPAdes v3.9.0 (5) (4). Gaps were closed by PCR and Sanger-sequencing 
(Genewiz, South Plainfield, NJ) to yield finished plasmid assemblies. Open reading 
frames were annotated for coding sequence using prokka (6). Antibiotic resistance 
genes were additionally annotated with Resfams and the ResFinder web server 
(https://cge.cbs.dtu.dk/services/ResFinder/) (7, 8). pPM187 and pPR1 plasmid maps 
were made by viewing the gff3 files in DNAPlotter and manually annotated for putative 
open reading frame function(9). Select T4SS genes were submitted to blastp against 
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Chapter 3: Population structure, antibiotic resistance, and uropathogenicity of 
Klebsiella variicola 
3.1 Abstract 
Klebsiella variicola is a member of the Klebsiella genus and often misidentified as 
Klebsiella pneumoniae or Klebsiella quasipneumoniae The importance of K. pneumoniae 
human infections has been known has been known due; however, a dearth of relative 
knowledge exists for K. variicola. Despite its growing clinical importance, comprehensive 
analyses of K. variicola population structure and mechanistic investigations of virulence 
factors and antibiotic resistance genes have not yet been performed. To address this, we 
utilized in silico, in vitro, and in vivo methods to study a cohort of K. variicola isolates and 
genomes. We found that the K. variicola population structure has two distant lineages 
composed of two and 143 genomes, respectively. 10/145 of K. variicola genomes 
harbored carbapenem resistance genes and 6/145 contained complete virulence 
operons. While the β-lactam blaLEN and quinolone oqxAB antibiotic resistance genes were 
generally conserved within our institutional cohort, unexpectedly 11 isolates were 
nonresistant to the β-lactam ampicillin and only one isolate was nonsusceptible to the 
quinolone ciprofloxacin.  K. variicola isolates have variation in ability to cause urinary tract 
infections in a newly developed murine model, but importantly a strain had statistically 
significant higher bladder colony forming units compared to the model uropathogenic K. 
pneumoniae strain TOP52. Type 1 pilus and genomic identification of altered fim operon 
structure were associated with differences in bladder colony forming units for the tested 
strains. 9 newly reported types of pili genes were discovered in the K. variicola pan-
genome, including the first identified P-pilus in Klebsiella spp. Infections caused by 
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antibiotic resistant bacterial pathogens is a growing public health threat. Understanding 
of pathogen relatedness and biology is imperative for tracking outbreaks and developing 
therapeutics. Here, we detail the phylogenetic structure of 145 K. variicola genomes from 
different continents. Our results have important clinical ramifications as high-risk antibiotic 
resistance genes are present in K. variicola genomes from a variety of geographies and 
as we demonstrate that K. variicola clinical isolates can establish higher bladder titers 
than K. pneumoniae. Differential presence of these pilus genes in K. variicola isolates 
may indicate adaption for specific environmental niches. Therefore, due to the potential 
of multidrug resistance and pathogenic efficacy, identification of K. variicola and K. 
pneumoniae to a species level should be performed to optimally improve patient 
outcomes during infection. This work provides a foundation for our improved 
understanding of K. variicola biology and pathogenesis.  
3.2 Introduction  
Klebsiella variicola was initially believed to be a plant-associated, distant lineage of 
Klebsiella pneumoniae, however it has subsequently been recovered from human 
clinical specimens(1). Despite increasing knowledge on the distinctness of K. variicola, 
K. pneumoniae and Klebsiella quasipneumoniae, misidentification within the clinical 
microbiology lab commonly occurs (2, 3).  This may have clinical implications, as one 
study demonstrated that K. variicola-infected patients have higher mortality than K. 
pneumoniae-infected patients (4). Furthermore, several virulence genes (VGs) including 
siderophores, allantoin utilization genes, and glycerate pathway genes have been 
reported in select K. variicola strains (5, 6). K. variicola has been shown to contain a 
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large pan-genome that is distinct from K. quasipneumoniae and K. pneumoniae, but the 
functional consequences of differential gene content has not been explored (2, 7).  
In this study, we retrospectively analyzed a cohort of Klebsiella isolates collected from 
2016-2017 at Washington University in St. Louis School of Medicine/Barnes-Jewish 
Hospital Clinical Microbiology Laboratory (WUSM) for possible K. variicola strains using 
matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-
TOF MS) and yggE PCR/restriction fragment length polymorphism (RFLP) assays. We 
performed Illumina whole-genome sequencing (WGS) to compare K. variicola from our 
institution with publicly available genomes in the first global evaluation of this species. 
We particularly focused on annotation of canonical Klebsiella VGs and ARGs, and then 
assessed their functional consequences using in vitro assays and in vivo murine 
infections. Our results demonstrate that population structure, antibiotic resistance, and 
uropathogenicity of K. variicola are generally similar to K. pneumoniae, but variability 
among K. variicola genomes has important clinical implications with varying strain 
efficacy in a murine model of urinary tract infection (UTI).  
3.3 Results 
3.3.1 Average nucleotide identity can delineate Klebsiella variicola from related 
species 
We performed Illumina WGS on 113 isolates that are commonly misidentified as K. 
pneumoniae (K. variicola (n=56), K. quasipneumoniae (n=3), K. pneumoniae (n=53), 
and Citrobacter freundii (n=1)). They were identified by Bruker biotyper MALDI-TOF MS 
and yggE RFLP assays from a variety of adult infection sites. The isolates were 
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retrieved from the Barnes-Jewish hospital clinical microbiology laboratory (St. Louis, 
MO, USA) in 2016-2017. We used pyANI with the mummer method to calculate the 
pairwise average nucleotide identity (ANIm) between the isolates in our cohort and 
retrieved publicly available Klebsiella genomes (n=90)(8, 9). The C. freundii was 
originally classified as K. pneumoniae from the VITEK MS MALDI-TOF MS v2.3.3 but 
was later determined to be Citrobacter freundii by Bruker Biotyper MALDI-TOF MS. The 
yggE PCR/RFLP was indeterminate for this isolate. Confirmatory yggE PCR/RFLP had 
94.6% (53/56) concordance with MALDI-TOF for prediction of K. variicola within our 
cohort (Figure 3.3.1). While one genome was dropped from downstream analysis, the 
other 55 WUSM K. variicola genomes all had > 95% ANIm with the reference genome 
of K. variicola At-22(5). K. variicola HKUPOLA (GCA_001278905.1) had > 95% ANIm 
with K. quasipneumoniae ATCC 7000603 reference genome but not K. variicola At-22, 
indicating that it is likely a misannotated K. quasipneumoniae and not a K. variicola. The 
remainder of the NCBI K. variicola genomes clustered with K. variicola At-22 and the 
WUSM K. variicola cohort. 100% (41/41) of the K. pneumoniae genomes from NCBI 
that were suspected to be K. variicola due to BLAST similarity had > 95% ANIm with K. 
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variicola At-22 but not K. pneumoniae HS11286 or K. pneumoniae CAV1042 (Figure 
3.3.1).  
Hierarchical clustering of the pairwise ANIm values replicated previous phylogenetic 
analysis showing that K. pneumoniae and K. quasipneumoniae are more closely related 
to each other than to K. variicola (Figure 3.3.1). Interestingly, the clustering pattern 
within K. variicola indicated that two isolates, KvMX2 (FLLH01.1) and YH43 
(GCF_001548315.1), are more closely related to one another than to the remainder 
(143/145) of the K. variicola genomes. Given that K. quasipneumoniae can be 
differentiated into two subspecies based on ANI with the BLAST method (ANIb), we 
used the JSpecies ANIb program to specifically compare KvMX2 and YH43 with K. 
pneumoniae ATCC BAA-1705, K. quasipneumoniae ATCC 7000603, and 3 other K. 
Figure 3.3.1  Pairwise Average Nucleotide Identity Clustermap of WUSM and NCBI Klebsiella 
Hierarchical clustering and heatmap of pairwise ANIm values among all isolates. The source of 
isolates (WUSM or NCBI) and initial species delineation (K. variicola, K. pneumoniae, or K. 
quasipneumoniae) are shown as colored bars adjacent to the heatmap. The three major blocks are 
labeled by their final species determination. 
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variicola genomes(10). KvMX2 and Yh43 have 98.02% ANIb with one another but an 
average of 96.67% ,96.65%, 96.68% ANIb with WUSM_KV_53, WUSM_KV_15, and K. 
variicola At-22, respectively. Consistent with our pyANI ANIm result, none of the K. 
variicola strains had >95% ANIb with K. pneumoniae ATCC BAA-1705 or K. 
quasipneumoniae ATCC 7000603. These data suggest that MALDI-TOF MS or yggE 
PCR/RFLP may be effective means to differentiate K. variicola from K. pneumoniae in 
the absence of WGS. 
3.3.2 Klebsiella variicola is composed of two distantly related lineages 
Core-genome alignment of the 1,262 genes at 90% identity shared by strains in all 
Klebsiella species and a Kluyvera georgiana outgroup show that the K. variicola isolates 
are in a cluster with K. pneumoniae, K. quasipneumonie, and the newly described K. 
quasivariicola(11). Core genome alignment of the 3,430 core-genes at 95% nucleotide 
identity for the entire gene length by all 145 K. variicola genomes indicate that KvMX2 
and Yh43 are distantly related to the other 143 genomes (Figure 3.3.2a). These other 
genomes form a star-like phylogeny showing deep-branching clusters radiating from the 
center of the tree. FastGear, which uses hierBAPS to identify lineages and then 
searches for recombination between lineages, supported the differentiation of KvMX2 
and Yh43into a separate lineage from the other genomes and identified 6 instances of 
recombination between these two lineages(12, 13). 
Phylogenomic network analysis and quantification of recombination from parSNP 
showed minimal recombination within the 143 K. variicola lineage 2 genomes, with 
approximately 1.62% of the K. variicola genome believed to be recombinant (14). The 
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Figure 3.3.2. Population structure of K. variicola genomes  
(a) Approximate-maximum-likelihood tree of the total 145 K. variicola genomes and annotation of 
FastGear lineage identification. (b) Recombination free parSNP tree of the closely related lineage 2 
genomes with quantitative clustering from ClusterPicker added as alternating teal and brown labels 
adjacent to Cluster number (1-26). Bootstrap support values below 80% are depicted as node labels. 
Monophyletic groups of these clusters were colored if they were similar in (c) the dendrogram showing 
the evolutionary context of the cluster when compared to K. pneumoniae (KP), K. quasipneumoniae 
(KQ), and K. aerogenes (KA). Relevant metadata shows for initial identification, geographic location, 
source of isolation, and body site are adjacent to the assembly names. Bootstrap support values below 
80% are depicted as node labels. 
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common ancestor into equally distant clades across different environments. Quantitative 
clustering of the 143 genomes in the second lineage with ClusterPicker showed that 
56.6% (81/143) genomes fall into 26 clusters, with 57.7% (15/26) of the clusters 
containing more than 2 genomes (Fig. 2b)(15). Only 46.2% (12/26) of clusters contain 
isolates from both WUSM_KV and NCBI. The largest clusters, 24 and 21, each contain 
7 genomes. Cluster 21 contained WUSM_KV_10 and 6 genomes from an analysis of 
patient isolates at an intensive care unit in Seattle, Washington (USA). Although they 
were in the same cluster WUSM_KV_10 differed from these isolates at 1,882 sites 
across the 4,867 genes shared at 95% identity. 
To better understand the context of the 4 groups in lineage 2, we aligned the 2,932 
genes shared among the 145 K. variicola genomes, Klebsiella (Formerly Enterobacter)  
aerogenes KCTC 2190, K. quasipneumoniae ATCC 700603, and K. pneumoniae ATCC 
BAA-1705 at >90% identity to create a dendrogram (Figure 3.3.2c). This method 
preserved the conservation of the lineage 2 groups but showed a different order. The 
only discrepancy observed is that in the lineage 2 phylogenetic tree, cluster 3 appeared 
to be in the A group, however, both 521_SSON and 524_SBOY are more similar to C 
group genomes in the dendrogram. This incongruency is consistent with cluster 3 
radiating away from cluster 4 near the center of the phylogenetic tree (Figure 3.3.2b). 
Addition of metadata onto the dendrogram showed that the K. variicola cohort spans 
most geographic locations, with the notable exception of Africa and Oceania (Figure 
3.3.2c). The K. variicola genomes showed a remarkable level of source diversity, with 
representative isolates from animals (n=4), fungi (n=2), plants (n=7), water (n=3), and 
industrial waste (n=6). However, as a testament to the pathogenic potential of K. 
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variicola, 79.5% (114/145) genomes came from sites associated with humans.  Of the 
human-associated sites, 40.4% (46/114) came from urine and 19.2% (22/114) came 
from blood (Figure 3.3.2c). We did not observe any apparent association with 
geography, habitat, or infection site for any of the K. variicola clades. 67/145 isolates 
had a sequence type (ST) identified using the K. pneumoniae multilocus sequence type 
scheme. Consistent with the distance between lineages, 44 different STs were 
identified. ST1562 and ST641 had the highest number of isolates (n=4). In summary, 
these data demonstrate that K. variicola has diverse population structure and can be 
found in a variety of environmental and host niches.  
3.3.3 Acquired ARGs and VGs are not restricted to any K. variicola cluster  
We applied ResFinder to determine the burden of acquired ARGs amongst the K. 
variicola strains (Figure 3.3.3a) (16). β-lactamase genes were the most abundant ARG 
in the K. variicola cohort (n = 26). As expected, blaLEN was almost universally 
conserved, as 837_KPNE was the only isolate without one identified. 10 different blaLEN 
alleles were found. blaLEN-16 was most common (51/145), followed by blaLEN-24 (40/145) 
and blaLEN-2 (31/145). Carbapenemases were rare but blaKPC-2 (4/145), blaKPC-6 (1/145), 
blaNDM-1 (1/145), blaNDM-9 (3/145), and blaOXA-48 (1/145) were each identified across a 
total of 10/145 strains. blaCTX, blaSHV, blaTEM, and non-carbapenemases blaOXA genes 
were also identified, but we did not detect any Class C β-lactamase genes or non-
blaNDM Class B β-lactamase genes. Aminoglycoside ARGs (n=10), including members 
of the aac, aad, aph, and str families, comprised the second most abundant class. 
ARGs against folate synthesis inhibitors (n=8), quinolones (n=7), amphenicols (n=4), 
tetracyclines (n=2), macrolides/lincosamides/streptogramins (n=2), and fosfomycin 
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(n=1) were also found (Fig. 3a). In addition to the near-total conservation of blaLEN, the 
quinolone efflux pump components oqxAB were found in almost all isolates (139/145). 
Across the 145 genomes, the median and mode number of ARGs were both 3. 6.89% 
(10/145) genomes harbored > 10 ARGs, including WUSM_KV_55 from our cohort.  
We used the K. pneumoniae BIGSdb database 
(bigsdb.pasteur.fr/klebsiella/klebsiella.html) and BLASTN to identify canonical Klebsiella 
Figure 3.3.3 Distribution of acquired antibiotic resistance and virulence genes in the K. 
variicola cohort 
Presence/Absence matrix of ARGs (a), virulence genes (b) , and plasmid replicons (c) ordered 
for all K. variicola genomes against the dendrogram from Figure 3.3.2c. 
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VGs in the K. variicola strains (Figure 3.3.3b). In contrast to ARGs, previously 
characterized Klebsiella VGs were found only sporadically in the K. variicola cohort. 
Interestingly, the all allantoin utilization operon, arc, fdrA, gcl, glxKR, hyi, and ybbWY 
genes were found in the distantly related YH43genome as well as the closely related 
BIDMC90, k385, and WUSM_KV_03 genomes. Irp12 and the ybt operon were found 
together in the three isolates 50878013, MGH 20, and WUSM_KV_10. Irp1 was found 
on 3 additional instances but with no other VGs. Among 8 isolates containing the full all 
or ybt operon, six had only 3 ARGs; however, 50878013 contains the ybt operon, irp12, 
and has 5 ARGs including the blaOXA-48 carbapenemases, while k385had 17 ARGs but 
no carbapenemases. 
3.3.4 WUSM K. variicola cohort are susceptible to most antibiotics  
We constructed a network diagram of ARGs and isolates to identify connectivity within 
the K. variicola strains from our cohort (Figure 3.3.4a). WUSM_KV_55 had twice as 
many ARGs (n=12) as the next closest isolate, WUSM_KV_26 (n=6). Most notably, 
WUSM_KV_55 contained the carbapenemase gene blaKPC-2. In addition to the core β-
lactamase blaLEN-2, this isolate also contained a blaCTX-M-14 gene. Redundancy was again 
observed for the ARGS against aminoglycosides and sulfonamides, as WUSM_KV_55 
contained aac(6’)lb-cr, aadA16 and sul1, sul2. Within our cohort, this isolate was the 
only isolate found to harbor additional quinolone (qnrB6), rifampin (arr-3), and 
amphenicol (floR) ARGs. Interestingly, it possesses oqxB but not oqxA. Conversely, 
WUSM_KV_35 harbored the lowest number of acquired ARGs, as it lacked oqxAB but 
carried blaLEN-24.  
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We used Kirby-Bauer disk diffusion to quantify phenotypic resistance of the WUSM K. 
variicola strains to several clinically relevant antibiotics (Figure 3.3.4b). Klebsiella 
species are generally considered intrinsically resistant to ampicillin due to a conserved 
β-lactamase gene. In our cohort, 3/55 isolates were unexpectedly susceptible to 
ampicillin while the rest were resistant. Despite phenotypic sensitivity to ampicillin, the 
genomes for WUSM_KV_25, WUSM_KV_34, and WUSM_KV_82 encode blaLEN-24, 
blaLEN22, and blaLEN-16, respectively. These blaLEN alleles were also found in isolates 
intermediate and resistant to ampicillin. As expected, WUSM_KV_55 was the only 
isolate resistant to both meropenem and ceftazidime, presumably due to carriage of 
blaKPC-2. Additionally, it was the only isolate intermediate to ciprofloxacin. Four isolates 
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were resistant to trimethoprim-sulfamethoxazole, but only WUSM_KV_50 and 





Review of 2017 composite antibiogram from a microbiology laboratory serving 5 
hospitals in the St. Louis region (Missouri, USA), based on first isolate per patient per 
year, revealed that, in general, K. pneumoniae (n = 1522) had decreased susceptibility 
to all reported antimicrobials compared to K. variicola (n=144), except for meropenem 
(99% susceptibility for both species). Most notably, K. pneumoniae exhibited decreased 
susceptibility, as compared to K. variicola, with ampicillin-sulbactam (63 vs 93% 
susceptible), nitrofurantoin (66 vs 86% susceptible), and trimethoprim-sulfamethoxazole 
(80 vs 90% susceptible). 
3.3.5 Changes in fim operon are associated with uropathogenicity in a murine UTI 
model 
Given that 70% (39/56) of K. variicola strains from our cohort were isolated from the 
human urinary tract, we wanted to assess uropathogenicity in a diverse subset of these 
isolates. We transurethrally inoculated C3H/HeN mice with 107 CFU/ml of 5 individual K. 
variicola strains, or the model uropathogenic K. pneumoniae TOP52 strain, for 
comparison (Figure 3.3.5a) (3, 17, 18). Similar to previously published infections with K. 
pneumoniae TOP52, the K. variicola strains exhibited large variations in bacterial 
Figure 3.3.4 WUSM K. variicola have a low burden of ARGs and are generally 
susceptibly to antibiotics 
(a) Network diagram depicting each WUSM_KV isolate and ARG as nodes. ARGs are colored 
in accordance with predicted phenotypic resistance from ResFinder, and WUSM_KV genomes 
are colored by the burden of ARGs. (b) Scatterplots depicting Kirby-Bauer disk diffusion size 
(mm) from phenotypic susceptibility testing. Each plot represents an isolate, and the plots are 
colored according to CLSI interpretation. Those with atypical resistance are listed by name 
with putative ARGs. 
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colony-forming units (CFUs) recovered from the bladder at 24 hours post infection (hpi). 
When compared to TOP52, WUSM_KV_39 was the only isolate with a significantly 
increased bladder burden (P=0.0094).  Bacterial loads of WUSM_KV_10 and 
WUSM_KV_39 were both significantly higher than WUSM_KV_09 and WUSM_KV_14 
(Figure 3.3.5a). Despite this variability among bladder CFU results, the results of kidney 
titers 24 hpi were not significantly different among strains by ANOVA (P=0.1270). As 
observed in the bladder, though, WUSM_KV_10 and WUSM_KV_39 achieved 
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controlled by 
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invertible DNA 
Figure 3.3.5 Changes in fim operon are associated with outcomes in 
mouse UTI model 
(a) CFU/bladder and CFU/kidney of K. pneumoniae TOP52 and WUSM_KV 
isolates 24 hour post transurethral bladder inoculation of C3H/HeN mice. Short 
bars represent geometric means of each group and dotted lines represent limits 
of detection.  (b) fimS phase assay and quantification with respective bands 
indicating the “ON” and “OFF” position labeled. (c) Immunoblot for FimA and 
GroEL, with quantification shown below. (d) EasyFig illustration of genes in the 
fim operon and JALview of the nucleotides and amino acids for the fimB/fimE 
intergenic region and fimD gene. 
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(fimS site)(19, 20). Orientation of the fimS site in the “ON” position enables production 
of type1 pili and increased urovirulence. Under identical growth conditions, 
WUSM_KV_39 had a higher population with the fimS promoter region in the “ON” 
orientation compared to the other strains tested (Figure 3.3.5b).  Furthermore, 
consistent with its success in the bladder, WUSM_KV_39 was found to produce the 
greatest amount of FimA (the main structural component of type 1 pili), as measured by 
immunoblot (Figure 3.3.5c).  WUSM_KV_03, WUSM_KV_09, and WUSM_KV_39 all 
produced significantly more FimA than K. pneumoniae TOP52. Interestingly, 
WUSM_KV_14 did not produce appreciable levels of FimA by this assay (Figure 
3.3.5c).  
As we discovered significant variability in type 1 piliation, we specifically investigated 
changes in fim operon sequence between these isolates by viewing the prokka coding 
sequence annotation in EasyFig and JALview (Figure 3.3.5d)(21, 22). We found that 
WUSM_KV_14 had a predicted truncated FimD usher sequence.  A guanine-to-adenine 
single nucleotide polymorphism (SNP) in the fimD gene changed a predicted tryptophan 
residue into a premature stop codon, likely explaining the observed lack of production of 
type 1 pili.   Additionally, in WUSM_KV_39, prokka annotated a hypothetical protein in 
the intergenic region between fimB and fimE and included a gap replacing a thymine 
and a guanine-to-adenine SNP. The altered fimB/fimE intergenic region in 
WUSM_KV_39 may play a role in its increased expression of type 1 pili. Together, 
these data demonstrate that variation exists amongst K. variicola genomes that may 
account for differential urinary tract niche proclivity among isolates.    
3.3.6 K. variicola encodes both conserved and novel usher genes 
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The fim operon is one of the best characterized chaperone-usher pathways (CUP); 
given the observed importance of the fim operon in K. variicola uropathogenicity, we 
searched the pan-genome of our K. variicola cohort to identify the complete repertoire of 
CUP operons(23). 17 unique usher sequences at 95% identity were identified across 
the 55 WUSM K. variicola genomes, and an amino acid sequence alignment showed 
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that they were distributed in 5 Nuccio & Baumler clades (Figure 3.3.6a)(24). From this 
analysis we discovered 9 new usher genes previously undescribed in Klebsiella, which 
we name kva-kvi. KviA and KveB usher sequences were found to cluster within the pi 
(π) clade, making them the first description of a P pilus apparatus in Klebsiella. The 
recently named γ* subclade contained the greatest amount (7/17) of K. variicola usher 
Figure 3.3.6 K. variicola encodes both conserved and novel usher genes 
 (a) Approximate-maximum-likelihood tree of the usher amino acid sequences described by 
Nuccio & Baumler and representatives of the 17 usher sequences identified in the WUSM_KV 
pan-genome. (b) Hierarchical clustering of the presence/absence matrix of each and 
annotation of relevant features related to each usher.  
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sequences; 5 of these 7 were previously reported in K. pneumoniae, while KvcC and 
KvdB are first reported here.  
FimD, and the usher sequences for KpaC, KvaB, KpeC, and KpjC were present in all 55 
WUSM K. variicola isolates (Figure 3.3.6b). KvgC, KvhC, KviA, and KpcC were each 
found in only one isolate. KpgC, MrkC, kvbC, KpbC, KvcC, KveB, KvfC, and KvdB can 
be considered accessory usher sequences in this cohort, as they were absent in certain 
strains. The most notable pattern evident from the hierarchical clustering of the 
presence/absence for all usher genes in our K. variicola cohort is that isolates 
WUSM_KV_10 through WUSM_KV_21 all carry the KvdB sequence but not KpbC.  
Eight of the 9 newly described usher sequences had highest BLASTP hits > 99% 
identity across the entire length of the gene against the non-redundant protein 
sequences database in April 2018 and all of them were previously annotated as being 
found in Enterobacteriaceae, Klebsiella, or K. variicola. All of the usher genes except kvi 
were in operons that included a chaperone, at least one subunit, and a putative 
adhesin. KvhC, the usher protein with the lowest BLASTP identify value, had 76% 
identity to several genes from Enterobacter species. The contig with the kvh operon 
also contained several genes that had possible roles in prophage integration and 
transposase activity. Our results indicate that K. variicola strains harbor a diverse set of 
usher genes, which may augment K. variicola fitness across a variety of environmental 




A previous phylogenomic study used split-network analysis to demonstrate that the K. 
variicola phylogroup (formerly KPIII) is distinct from K. pneumoniae (KPI) and K. 
quasipneumoniae (KPII) (25). As an orthogonal method, we used ANI software, the gold 
standard for in silico species delineation, to recreate this differentiation of phylogroups 
as separate species (8). Historically, differentiation between K. pneumoniae and K. 
variicola has been difficult, as evidenced by misannotation of K. variicola as K. 
pneumoniae in public genome sequence databases.  These misannotated K. variicola 
strains came from a variety of geographic regions and were not exclusive to any cluster. 
Within our sequenced cohort, differentiation of K. variicola from K. pneumoniae and K. 
quasipneumoniae using MALDI-TOF MS and yggE PCR/RFLP was supported by ANI. 
This indicates that yggE PCR/RFLP (3) would be a feasible alternative for clinical labs 
across the globe lacking access to MALDI-TOF MS or WGS. Additionally, hierarchical 
clustering of the ANI values and core-genome phylogeny demonstrated that 2 K. 
variicola genomes were distinctly separate from the other 143 in our cohort. ANIb 
values between these genomes with the other K. variicola genomes were ~96%, similar 
to what was observed for K. quasipneumoniae. The differences in ANIb values 
contributed to the delineation of K. quasipneumoniae into two subspecies, K. 
quasipneumonie subsp. quasipneumoniae and K. quasipneumoniae subsp. 
similpnumoniae (26). However, further phenotypic comparisons between FLLH01.1 and 
GCF_001548315 with other K. variicola isolates is required to unequivocally qualify 
these as separate subspecies. Further phenotypic comparisons, including the sole 
carbon source utilization used for differentiation of the K. quasipneumoniae subspecies, 
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between KvMX2/Yh43 and other K. variicola isolates is required to unequivocally qualify 
these as separate subspecies(26). 
Numerous studies have shown that K. pneumoniae has a deep-branching phylogenetic 
structure with minimal recombination occurring within K. pneumoniae strains and 
between K. pneumoniae and K. variicola/K. quasipneumoniae (25, 27). Importantly, 
though, large-scale recombination events may be clinically relevant, as evidenced by 
research on the origin of the frequently carbapenem-resistant ST258 lineage (28, 29). 
Our results demonstrate that like K. pneumoniae, K. variicola shows minimal 
recombination within its genome, and its population structure is composed of numerous 
clades in a star-like phylogeny. A star-like population structure with deep-branching 
relationship between isolates (n=29 and n=28) was also found in two previously 
published K. variicola phylogenetic trees(2, 30).  
Similar to our work, a previous investigation did not identify any geographic distinction 
when genomes from within the United States were compared to those from outside of 
the United States (2). The 6 genomes in cluster 23 with WUSM_KV_10 were from ICU 
patient samples in Seattle, Washington, which provides the first evidence of clonal 
groups responsible for K. variicola infections in some settings (31). Although they were 
closely related when compared against all K. variicola genomes, there was still 1,882 
SNPs between WUSM_KV_10 and the other 6 genomes. Interestingly, clusters were 
not restricted to human infections, as Cluster 24 contains 3 genomes from bovine 
mastitis (NL49, NL58, NL58) and hospital isolates (VRCO0246, VRCO00242, 
VRCO00244, and VRCO00243) (https://www.ncbi.nlm.nih.gov/bioproject/361595)(32).  
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As expected for K. variicola, blaLEN β-lactamases were the most conserved ARGs. A 
previous report unexpectedly found a K. variicola isolate that harbored the blaOKP gene 
commonly found in K. quasipneumoniae; however, we did not identify such instances 
within our cohort (2). Although chromosomally encoded in K. pneumoniae, fosA was 
identified in only 1/145 of the K. variicola genomes (33, 34).Additionally, as previously 
found in K. pneumoniae clinical isolate cohorts we found oqxAB efflux pump genes 
widespread across K. variicola genomes(35-37). Although these genes may be 
ubiquitous in K. variicola, 0/55 of isolates we tested had resistance to ciprofloxacin; the 
single example with intermediate susceptibility carried a qnrB6 gene. This is not atypical 
for Enterobacteriaceae possessing oqxAB, as one study found 100% prevalence of 
oxqAB in K. pneumoniae but no quinolone resistance (36). It is possible that for K. 
variicola, similar to K. pneumoniae, high expression of oqxAB is essential for phenotypic 
resistance to quinolones (35).  In K. pneumoniae, expansion of clonal groups are 
associated with carbapenemase carriage (i.e. ST258 and blaKPC) however we did not 
observe any associations between carbapenemase genes and K. variicola clusters. 
Indeed only 1.81% (1/55) of K. variicola within our institutional cohort had a 
carbapenemase gene and the regional resistance rate for meropenem between K. 
pneumoniae and K. variicola in 2017 was similar. blaNDM positive K. variicola have been 
identified in clinical and environmental samples but blaKPC positive genomes came 
exclusively from clinical sources. KPN1481 (blaNDM-1) was annotated as a urine derived 
isolate but GJ1, GJ2, and GJ3 (all blaNDM-9) were found in the Gwangju tributary in 
South Korea(2, 38). In contrast, WUSM_KV_55 (blaKPC-2) was isolated from 
bronchoalveolar lavage fluid, KP007 (blaKPC-2) from intraabdominal site, and 223/14 
43 
 
(blaKPC-6) from a laparotomy wound(39, 40). IncF plasmids, the most abundant replicon 
identified in the K. variicola cohort are known carriers of antibiotic resistance genes, 
including blaCTX-M and blaOXA β-lactamases(41). Consistent with their widespread 
identification in K. variicola, IncF plasmids are frequently found in K. pneumoniae and E. 
coli(42, 43). 
K. pneumoniae is the second leading cause of urinary tract infections (44). Given 
previous misclassification of K. variicola as K. pneumoniae and the high frequency at 
which K. variicola was isolated from the urinary tract, we were interested in comparing 
the uropathogenicity of our K. variicola isolates to the well-studied model K. 
pneumoniae TOP52 isolate (3, 17, 18). We identified strain-dependent virulence 
capacity, with UTI infections from WUSM_KV_39 yielding statistically significant higher 
bladder CFU than K. pneumoniae TOP52. Quantification of metrics used to study 
uropathogenicity in E. coli and K. pneumoniae show increased fimS in the “ON” 
orientation and increased FimA production by WUSM_KV_39; these findings provide a 
plausible explanation for why WUSM_KV_39 performed better than K. pneumoniae 
TOP52 and all WUSM_KV isolates excluding WUSM_KV_10 (45).  While we do not yet 
understand the role of the putative protein identified between recombinases fimB and 
fimE in WUSM_KV_39, one could postulate that this difference may affect fimbrial 
expression. Additionally, the poorest performer in the urinary tract, WUSM_KV_14, 
encodes a mutation resulting in a truncated fimD usher sequence which likely explains 
its lack of FimA production. As with other bacterial pathogens, it is likely that specific 
virulence factors are required for K. variicola competency in distinct body niches (46, 
47).  Further work is therefore warranted to test if yersinibactin and allantoin utilization 
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promote lung and liver infections, respectively, in K. variicola as they do in K. 
pneumoniae (48-51). 
K. variicola encodes usher genes previously identified in K. pneumoniae and 9 novel 
ushers (52). Interestingly, KveB and KviA are the first report of π usher proteins in 
Klebsiella. The best studied π operon, pap in E. coli, is a major contributor to 
pyelonephritis as the PapG adhesin can bind Gal-α (1–4)-Gal exposed on human 
kidney cells (53).  Other usher genes have been shown to be essential for biofilm 
formation, plant cell adhesion, and murine gut colonization, further demonstrating their 
role in niche differentiation (52). Clustering of the presence/absence of these ushers 
showed the absence of KpbC but presence of KvdB in 11 of the WUSM_KV genomes, a 
phenomenon similar to that observed for UshC and YraJ in E. coli(54). All 4 of these 
usher types were found in the γ* clade, suggesting an exclusionary form of functional 
redundancy between usher genes (54). Usher genes and CUP operons are frequently 
exchanged horizontally between Enterobacteriaceae genera (54). Indeed, we have 
found that the KvhC usher protein has only 76% amino acid identity to any existing 
proteins in the non-redundant protein sequence database and that the kvh operon is 
situated next to multiple prophage and transposase associated genes. 
In this investigation, we used phenotypic and genomic analyses to better understand 
the diversity of K. variicola genomes, both from our institution and across the globe 
(using publicly available NCBI genomes).  Then we assessed the functional 
consequences of ARGs and VGs towards antibiotic resistance and uropathogenicity. 
One limitation of our study is that our mouse infections and phenotypic analyses are 
performed with non-isogenic strains. If existing genetic modification systems in K. 
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pneumoniae are shown to be useful for gene knockouts in K. variicola, further work can 
be performed to mechanistically validate our findings. An additional limitation is that ~30 
genomes of K. variicola have been uploaded to NCBI since we initiated our comparison. 
These may further elucidate differences in population structure, although even with 
almost 300 genomes, one study indicates that K. pneumoniae diversity remains under 
sampled (25).  
Our work represents the first large-scale genomic analysis of K. variicola across multiple 
institutions and the first use of a murine model to study K. variicola pathogenesis. We 
unequivocally show that whole-genome comparisons can separate K. variicola from K. 
pneumoniae and offer convenient alternative methods for laboratories without access to 
WGS to differentiate these species. Importantly, we demonstrate that high-risk ARGs 
and VGs are present in K. variicola genomes from a variety of geographies. This may 
have clinical ramifications, as we demonstrate that some K. variicola clinical isolates 
can be superior uropathogens compared to K. pneumoniae. Similar to E. coli and K. 
pneumoniae, the diversity of CUP operons in these isolates could complement 
additional acquired virulence genes and enable infection of specific niches. Therefore, it 
is imperative that K. variicola and K. pneumoniae continue to be differentiated in the 
clinical laboratory, so that we may apply data on differential gene repertoire, clinical 
behavior, and niche specificity to the goal of ultimately improving patient outcomes. 
3.5 Materials & Methods 
3.5.1 Clinical Klebsiella Collection 
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113 clinical Klebsiella spp. isolates recovered in the Barnes-Jewish Hospital 
Microbiology laboratory (St. Louis, MO) from 2016-2017 were evaluated in this study. Of 
these, 56 were consecutively collected isolates identified by Bruker Biotyper MALDI-
TOF MS as K. variicola (research-use only database v6). This identification was 
confirmed using a PCR/restriction fragment length polymorphism (RFLP) assay 
targeting the yggE gene (F: 5′-TGTTACTTAAATCGCCCTTACGGG-3′; R: 5′-
CAGCGATCTGCAAAACGTCTACT-3′; restriction enzyme: BciVI) that was designed to 
distinguish K. variicola from K. pneumoniae. 94.6%  (53/56) confirmed as K. 
variicola using the yggE PCR-RFLP assay. 
  
The remaining 58 isolates were randomly selected from a banked collection of K. 
pneumoniae strains historically recovered from clinical specimens (29 from urine, 25 
from blood, and 1 each abdominal wound, tracheal aspirate, bronchial washing, and 
bile). Each of these isolates underwent Bruker MALDI-TOF MS and yggE PCR/RFLP to 
confirm their identification. Five percent (5%; 3/58) confirmed as K. variicola using 
MALDI-TOF MS and the yggE PCR-RFLP assay. 
3.5.2 Illumina Whole Genome Sequencing and publicly available Klebsiella 
genomes 
Pure frozen stocks of the presumptive 113 Klebsiella isolates were plated on blood agar 
to isolate single colonies. ~10 colonies were suspended using a sterile cotton swab into 
water, and total genomic DNA was extracted using the Bacteremia Kit (Qiagen). 0.5 ng 
of DNA was used as input for sequencing libraries using the Nextera kit (Illumina) (55). 
Libraries were pooled and sequenced on an Illumina NextSeq 2500 High Output system 
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to obtain ~2.5 million 2 × 150 bp reads. Demultiplexed reads had Illumina adapters 
removed with trimmomatic v.36 and decontaminated with DeconSeq v0.4.3 (56, 57). 
Draft genomes were assembled with spades v3.11.0, and the scaffolds.fasta files were 
used as input for QUAST v 4.5 to measure the efficacy of assembly (58, 59). All contigs 
>500 bp in length were annotated for open reading frames with prokka v1.12 (60). The 
genomes have all been deposited to NCBI under BioProject PRJNA473122.  
To increase the number of genomes for downstream analysis, 50 K. variicola genomes 
were obtained from NCBI genomes (https://www.ncbi.nlm.nih.gov/genome/) in 
September 2017. Additionally, as it is possible that previously sequenced K. variicola 
may be incorrectly described as K. pneumoniae, we submitted the complete genome of 
the K. variicola reference strain At-22 to NCBI BLASTN against the non-redundant 
nucleotide collection and the whole-genome shotgun sequence databases using default 
settings in September 2017. Using this method, we obtained 41 genomes of K. 
pneumoniae with the minimum observed query length of 38% at 99% identity. Given 
that the cohort of genomes analyzed in our study includes isolates initially 
misannotated, we refer to them as either the NCBI genome or assembly 
(https://www.ncbi.nlm.nih.gov/assembly) accession key. Sequenced and acquired 
isolates were analyzed using a variety of computational programs. In silico sequence 
typing was performed using mlst v2.11 (https://github.com/tseemann/mlst) and the 
BIGSdb database (bigsdb.pasteur.fr/klebsiella/klebsiella.html). 
3.5.3 Antimicrobial Susceptibility Testing 
K. variicola isolates underwent antimicrobial susceptibility testing per laboratory 
standard operating procedures using Kirby-Bauer disk diffusion on Mueller Hinton Agar 
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(BD BBL™ Mueller Hinton II Agar), in accordance with Clinical and Laboratory 
Standards Institute (CLSI) standards. Disk diffusion results were interpreted using 
CLSI Enterobacteriaceae disk diffusion breakpoints (CLSI. Performance Standards for 
Antimicrobial Susceptibility Testing. 27th ed. CLSI Supplement M100. Wayne, PA: 
Clinical and Laboratory Standards Institute; 2017). Briefly, 4-5 colonies from pure 
isolates were used to create a 0.5 McFarland suspension of the organism in sterile 
saline. A sterile, non-toxic cotton swab was dipped into the bacterial suspension, and a 
lawn of the organism was plated to Mueller-Hinton agar. Antimicrobial Kirby-Bauer disks 
were applied, and the plate was incubated at 35°C in room air for 16-24 h. The 
diameters of the zones of growth inhibition surrounding each antimicrobial disk were 
recorded in mm. 
3.5.4 Mouse Urinary Tract Infections 
Bacterial strains from our K. variicola cohort and K. pneumoniae TOP52 were used to 
inoculate 7- to 8-week-old female C3H/HeN mice (Envigo) by transurethral 
catheterization as previously described (17, 18, 61).  The K. variicola strains were 
selected to encompass a range of genetically distinct isolates. WUSM_KV_03 and 
WUSM_KV_10 were specifically chosen as they contain the all and ybt operons, 
respectively. Static 20-mL cultures were started from freezer stocks, grown in Luria-
Bertani (LB) broth at 37°C for 16 h, centrifuged for 5 min at 8,000 × g, and the resultant 
pellet was resuspended in phosphate-buffered saline (PBS) and diluted to 
approximately 4 × 108 CFU/ml. Fifty mL of this suspension was used to infect each 
mouse with an inoculum of 2 × 107 CFU/ml.  Inocula were verified by serial dilution and 
plating. At 24 hpi, bladders and kidneys were aseptically harvested, homogenized in 
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sterile PBS via Bullet Blender (Next Advance) for 5 min, serially diluted and plated on 
LB agar.  All animal procedures were approved by the Institutional Animal Care and Use 
Committee at Washington University School of Medicine. 
3.5.5 Phase Assays 
To determine the orientation of the fimS phase switch in Klebsiella, a phase assay was 
adapted as previously described (19).  An 817 bp fragment including fimS was PCR 
amplified using Taq polymerase (Invitrogen) and the primers 5’-
GGGACAGATACGCGTTTGAT-3’ and 5’-GGCCTAACTGAACGGTTTGA-3’ and then 
digested with HinfI (New England Biolabs).  Digestion products were separated by 
electrophoresis on a 1% agarose gel.  A phase-ON switch yields products of 605 and 
212 bp, and a phase-OFF switch yields products of 496 and 321 bp.  
3.5.6 FimA and GroEL Immunoblots 
Acid-treated, whole-cell immunoblotting was performed as previously described using 
1:2,000 rabbit anti-type 1 pilus and 1:500,000 rabbit anti-GroEL (Sigma-Aldrich) primary 
antibodies(62, 63). Amersham ECL horseradish peroxidase-linked donkey anti-rabbit 
IgG (GE Healthcare) secondary antibody (1:2,000) was applied, followed by application 
of Clarity enhanced chemiluminescence (ECL) substrate (Bio-Rad Laboratories).  The 
membrane was developed and imaged using a ChemiDoc MP Imaging System (Bio-





CFU/bladder and CFU/kidney for both experimental replicates were used as input for 
ordinary one-way ANOVA to judge significance. Pairwise comparisons of CFU/bladder 
and CFU/kidney values were performed by using the nonparametric Mann-Whitney U 
test. Similarly, normalized quantifications of relative FimA amounts (FimA/GroEL) and 
fimS in “ON” position (fimS “ON”/fimS “OFF”) were compared using the Mann-Whitney 
U test.  All P values <0.05 were considered significant, and all calculations were 
performed in GraphPad Prism v7.04. 
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Chapter 4:  Spatiotemporal dynamics of multidrug resistant bacteria on intensive 
care unit surfaces 
4.1 Abstract 
Bacterial pathogens that infect hospital patients also contaminate hospital surfaces. 
These surface contaminants impact hospital infection control and epidemiology, but 
spatial, temporal, and phylogenetic relationships of these diverse bacteria are still under 
exploration. We investigate spatiotemporal and phylogenetic relationships of multidrug 
resistant bacteria on intensive care unit surfaces from two hospitals in the United States 
and Pakistan  
collected over a year. These bacteria include common nosocomial pathogens, rare 
opportunistic pathogens, and novel taxa. Most of our common nosocomial isolates are 
dominated by single lineages composed of different clones, are phenotypically multidrug 
resistant, and have high resistance gene burdens. Many resistance genes are shared by 
multiple species and are flanked by mobilization elements. With permutation testing we 
identify Acinetobacter baumannii and Enterococcus faecium co-association, and our in 
vitro experiments find supporting synergistic biofilm interactions. Our results highlight 
drug resistant nosocomial pathogen burdens in hospital built-environments, provide 
evidence for spatiotemporal dependent transmission, and demonstrate a potential 
mechanism for dual-species bacterial surface persistence.  
4.2 Introduction 
Global treatment of bacterial infections is increasingly compromised by evolution 
and transmission of multidrug resistant organisms (MDROs) and their antibiotic 
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resistance genes (ARGs) between multiple habitats(1). Infections caused by MDROs are 
associated with increased mortality risk compared to infections by matched species 
susceptible isolates(2-4). Through international travel, clonal expansion, and 
promiscuous mobile genetic elements, MDROs and the ARGs they harbor have rapidly 
swept across the globe(1, 5-11). Resistant infections cause over 23,000 annual deaths in 
the United States of America (USA) and cost the economy over 55 billion dollars(12). The 
annual global death toll from MDROs is at least 700,000 people(13). Improved 
surveillance and understanding of MDRO and ARG transmission are key factors in 
reducing these death tolls(1). 
Hospitalized patients are more vulnerable to bacterial infections than the general 
population(14), and healthcare associated infections (HAIs) acutely threaten patient 
safety worldwide(15, 16). The ‘ESKAPE’ pathogens, named by the Infectious Disease 
Society of America, are common causes of HAIs and the most common MDROs(17). 
These include the gram-positive microorganisms Enterococcus spp. and Staphylococcus 
aureus, and the gram-negative microorganisms Klebsiella pneumoniae, Acinetobacter 
baumannii, Pseudomonas aeruginosa, and Enterobacter spp.(17). These ESKAPE 
pathogens can be acquired while hospitalized, but some patients may be colonized or 
infected prior to hospital admission(18). Patients harboring these putative pathogens can 
transmit these bacteria to healthcare workers, other patients, medical equipment, and 
hospital surfaces(18), but the contribution of this contamination route compared to other 
routes in unknown. The presence of these microorganisms on surfaces in healthcare 
settings is a local and global public health concern(19). Some putatively pathogenic 
strains of bacteria persist for months on hospital surfaces, and they may even survive 
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surface decontamination efforts, partly aided by biofilm formation(20-23). Though studies 
clearly demonstrate that bacterial pathogens exist on hospital surfaces, key knowledge 
gaps exist regarding the levels, types, and dynamics of contamination in hospitals from 
different geographies(14, 18). Specifically, there is a lack of information on the spatial, 
temporal, and phylogenetic relationships between different bacterial taxa on surfaces 
from countries endemic for a high burden of ARGs. This information gap is especially true 
for physical colocalization and horizontal gene transfer between clinically relevant 
ESKAPE pathogens and benign environmental bacteria. 
Monitoring high contact surfaces for clinically relevant pathogenic bacteria and 
understanding the dynamics of their persistence and spread is one approach to thwart 
MDRO transmission and protect vulnerable hospitalized patients(24). Additionally, such 
surveillance provides an opportunity to identify and characterize potential emerging 
pathogens before they are recognized in clinical infections(12, 25). 
To address the question of MDRO spatiotemporal dynamics and persistence on 
healthcare surfaces we conducted a year-long longitudinal study at a tertiary care hospital 
in Pakistan (PAK-H) where endemic ARG burden is high(26-28). A previous investigation 
found differing resistance mechanisms to last-resort carbapenem antibiotics in genetically 
similar Enterobacteriaceae strains and plasmids isolated from hospitals in Pakistan and 
the USA(29). Accordingly, we included a matched tertiary care hospital in the USA (USA-
H) as a comparison group. For our collections and subsequent analysis, we took an 
Eulerian approach by selecting and measuring fixed hospital surfaces over time to 
understand bacterial contamination dynamics. This approach allows us to leverage 
collection time information and surface spatial information to draw epidemiological 
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insights. In both hospitals, we sampled 4 intensive care unit (ICU) rooms with 5 surfaces 
in each room (Figure 4.3.1). We collected surface swabs every other week for 3 months, 
and again at 6 months, and at 1 year, for a total of 180 samples per hospital. We identified 
high burdens of known MDROs on PAK-H ICU surfaces including ESKAPE pathogens 
and novel taxa(30). This investigation is the first from Pakistan to show such widespread 
contamination with multidrug resistant, extensively drug resistant, and pan-drug resistant 
bacteria. We found evidence that bacteria are non-randomly distributed on hospital 
surfaces with respect to both space and time, and we used this information to narrow 
possible contamination routes. We found cross-contamination of MDRO clones both 
across different surfaces within rooms, as well as between rooms at the same sampling 
time-points. From our results, it is likely that bacteria are seeded to hospital surfaces from 
diverse human and/or environmental reservoirs in a time dependent manner. These 
seedings result in waves of contamination that are often, but not always restricted to a 
single collection time. We show high numbers of ARGs are shared between common 
nosocomial pathogens and rarer bacterial species, including several novel taxa which are 
close phylogenetic relatives to nosocomial pathogens. Co-association analysis of A. 
baumannii and E. faecium led us to identify synergistic biofilm formation between these 
two ESKAPE pathogens. This discovery points to a possible explanation of bacterial 
persistence on hospital surfaces. Longitudinal persistence of these high impact 
pathogenic species alongside highly resistant bacteria classically identified as 
"environmental" paints a concerning picture of hospital surface contamination. These 
results lay groundwork for future surveillance efforts and infection control interventions to 




4.3.1 PAK-H ICU surfaces had high bacterial burden 
 
We recovered 1163 bacterial isolates from hospital surfaces in PAK-H and 
predicted their species identities by MALDI-TOF MS. We chose a subset of 289 unique 
isolates for phenotypic and genomic analysis, using the criterion of a single isolate per 
unique MALDI-TOF MS identified species per culture condition per surface per time-point. 
These 289 bacteria represent 31 species and 10 families (Figure 4.3.2a). 25.9% (75/289) 
of isolates recovered from PAK-H were identified as A. baumannii. 16.2% (47/289) were 
the gram-positive pathogen E. faecium, and 11.8% (34/289) were K. pneumoniae. 
Interestingly, similar numbers of the soil-associated opportunistic pathogen 
Pseudomonas stutzeri were recovered (28/289, 9.7%) as the common nosocomial 
pathogen P. aeruginosa (27/289, 9.3%). In addition to these expected nosocomial 
organisms, we identified a variety of other clinically relevant species such as 
Figure 4.3.1 Bacterial isolate taxonomic identification and location. 
Samples were collected from surfaces longitudinally over the course of 1 year from PAK-H 
ICU and USA-H ICU. Four rooms from each ICU were chosen for sampling and five surfaces 
within each room were surveyed for every collection time. Bacteria were cultured from the 
collection swabs, identified by MALDI-TOF MS, and then whole-genome sequenced. 
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Stenotrophomonas maltophila, Shewanella putrefaciens, and Providencia rettgeri. These 
results starkly contrast with USA-H, where we only recovered 6 unique isolates which 
MALDI-TOF MS identified as A. baumannii (4/6) and E. coli (2/6) (Figure 4.3.2a). The 
majority of PAK-H (156/180, 86.7%) surface collections yielded bacteria (Figure 4.3.2b), 
but only a few (6/180, 3.3%) USA-H surface collections yielded isolates using the same 
culture conditions.  




Figure 4.3.2 MALDI-TOF Identification and distribution 
a MALDI-TOF MS identifications of bacterial isolates recovered from surfaces at PAK-H (above) and 
USA-H (below), colored by family. b Overview of PAK-H bacterial surface collections. Each horizontal 
gray panel represents a PAK-H room. Large, open black boxes are around any surface where one or 
more bacteria were collected. Blue squares are A. baumannii, red diamonds are E. faecium, green circles 
are K. pneumoniae, orange triangles are P. stutzeri, and purple triangles are P. aeruginosa. 
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We performed draft Illumina whole genome sequencing (WGS) on the 289 isolates to 
improve taxonomic resolution, quantify transmission dynamics for abundantly recovered 
organisms, and analyze ARG content. Initially, we constructed a Hadamard matrix, which 
represents the product of the average nucleotide identity (ANI) and percent of the genome 
aligned, between every pairwise combination of the 289 genomes sequenced from PAK-
H surfaces. Hierarchical clustering of Hadamard values confirms 74/75 isolates identified 
by MALDI-TOF MS as A. baumannii, 47/47 as E. faecium, 33/34 as K. pneumoniae, 27/27 
as P. aeruginosa, and 24/28 as P. stutzeri. These isolates cluster into the first 5 blocks. 
Analysis of the clustering pattern in the K. pneumoniae group found one isolate distant 
from the rest of the cohort; separate ANI analysis demonstrated this isolate is Klebsiella 
quasipneumoniae. Similarly, 3 isolates annotated as P. stutzeri are Pseudomonas 
xanthomarina. The isolate identified as A. baumannii that did not cluster with the rest of 
the cohort was Acinetobacter soli. In total, we found 27 cases where initial MALDI-TOF 
MS identifications differed from subsequent WGS dependent identifications. Additionally, 
both (2/2) isolates initially identified as Empedobacter brevis are Empedobacter falsenii. 
2/3 of genomically confirmed Atlantibacter subterranea were unidentified by MALDI-TOF 
MS but 1/3 was identified as the closely related Atlantibacter hermanii.  
We found 12 instances where genomes did not have > 95% ANI with the identified 
MALDI-TOF MS hit or the most closely related genomes as determined by 16S rRNA 
gene sequence in the EzBioCloud database, indicating that these are putative novel 
genomospecies. A separate investigation found that 2/7 of the isolates unidentified by 
MALDI-TOF MS are a new genus of multidrug resistant Enterobacteriaceae, termed 
Superficieibacter electus(30). The previously unreported genomospecies come from the 
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Caulobacteriacae, Xanthomonadaceae, and Enterobacteriaceae families, and 5 of the 
proposed new genomospecies are Pseudomonadaceae. Importantly, these unreported 
genomospecies are found on the same healthcare surfaces as common human 
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pathogens. Our results indicate WGS offers improved resolution for species delineation 
Figure 4.3.3 Phylogenetic trees of high abundance species from core genome alignments. 
Maximum likelihood phylogenetic trees from core genome alignments of A. baumannii (a), E. faecium (b), K. 
pneumoniae (c), and P. aeruginosa (d). Tree branches are colored by hierBAPS lineage and these lineages are 
colored in subsequent figures. Sequence type, week, room, and surface are annotated as colored bars next 
to the isolate number. Week is given as grayscale with darker values corresponding to later weeks. The US 
room that yielded isolates is annotated dark brown 
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compared to conventional clinical diagnostic tools, for both common human pathogens 
and rarer species. 







As our taxonomic analysis demonstrated A. baumannii, E. faecium, K. 
pneumoniae, and P. aeruginosa were the most abundant putative pathogens collected at 
PAK-H, we next endeavored to determine population structure for isolates in these 
species. For each species, we annotated protein coding sequences with Prokka, 
constructed core-genome maximum-likelihood phylogenetic trees with Roary and 
RAxML, then identified lineages with fastGEAR/BAPS(31-34). Our results demonstrate 
that for A. baumannii and E. faecium but not K. pneumoniae or P. aeruginosa, a single 
lineage represented >70% of all isolates collected over 12 months. For all four species, 
time of collection, but not room or surface had the greatest concordance with phylogenetic 
position.  
Figure 4.3.4 Relationship of core genome SNP groups to spatial and temporal distance.  
a Clonality results for A. baumannii. Squares represent A. baumannii collected from surfaces. Colors 
represent clonal subgroup membership. Each colored set is a clonal subgroup with fewer than five SNPs 
different between all members of the group. Unfilled squares did not have fewer than five SNPs different 
with any other isolates. Lineage from BAP (identified in Fig. 3 by branch color) is indicated in the legend on 
the left. b Clonality results for E. faecium. Diamonds represent E. faecium collected from surfaces. Colors 
represent clonal subgroup membership. Each colored set is a clonal subgroup with fewer than five SNPs 
different between all members of the group. Unfilled diamonds did not have fewer than five SNPs different 
with any other isolates. Lineage from BAP is indicated in the legend on the left. For c, d, temporal distances 
are calculated as +1 for every 2-week span separating isolate collections. Spatial distances are given as +0 
if isolates were collected from the same surface and room, +1 if they were collected from the same room, 
but different surfaces, and +2 if they were collected from different rooms. c Temporal linkage for A. 
baumannii clones. The expected temporal distance distribution is shown in blue and the observed temporal 
distribution is shown as a solid black line. d Spatial linkage for A. baumannii clones. The expected spatial 
distance distribution is shown in blue and the observed spatial distribution is shown as a solid black 
line. e Temporal linkage for E. faecium clones. The expected temporal distance distribution is shown in red 
and the observed temporal distribution is shown as a solid black line. f Spatial linkage for E. 
faecium clones. The expected spatial distance distribution is shown in red and the observed spatial 
distribution is shown as a solid black line.  
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88.4% (69/78) of the A. baumannii isolates were from lineage 7 (Figure 4.3.3a), 
which was composed of several untypable isolates, and 7 sequence types (STs). 
Interestingly, the 4 USA-H genomes in ST208 clustered adjacent to one another and next 
to the 7 ST208 genomes from PAK-H. 72.3% (34/47) of the E. faecium isolates come 
from BAPS lineage 4. All lineage 2 and lineage 1 E. faecium isolates came from the 2nd 
and 4th week, respectively. K. pneumoniae contained 5 BAPS lineages with ST617, 
ST337, ST231, and ST147 relating to lineages 1, 2, 4, and 5, respectively. All the lineage 
2 K. pneumoniae came from week 4 of our collections. P. aeruginosa had the greatest 
concordance between lineages and sequence types, as ST859, ST664, ST235, and 
ST571 corresponded to lineages 1, 2, 3, and 4, respectively. 74% (20/27) of the P. 
aeruginosa isolates came from week 8 of our collection, including all lineage 4 and lineage 
1 isolates. Our analysis of population structure for recovered A. baumannii, E. faecium, 
K. pneumoniae, and P. aeruginosa indicates that specific lineages of closely related 
isolates dominated PAK-H surfaces. We next wanted to investigate if clonal groups of 
highly related isolates existed within lineages we identified for these pathogens.  
4.3.4 Spatiotemporal distance identifies relevant epidemiologic groups 
To identify epidemiologically meaningful groupings, we leveraged space and time 
information from our collections. For A. baumannii and for E. faecium, we iterated through 
every unique variant distance cutoff from the lowest distance between any two isolates 
until the lowest distance between any two isolates not in the same lineage (Figure 4.3.4a-
e). We used these cutoffs to filter the isolate pairwise links edge list. For each cutoff, we 
found perfectly reciprocal groups with maximal graph coverage and recorded the number 
of cliques and the number of isolates per clique (Figure 4.3.4). Here we define cliques as 
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complete subgraphs within the network where each node in the clique is connected to 
each other node in the clique. Both A. baumannii and E. faecium showed a similar pattern 
where number of cliques rises sharply initially and then peaks. During this peak, there is 
a gradual increase in the number of isolates per clique, with cliques staying relatively 
balanced. After peaking, the number of cliques rapidly declines as formerly independent 
cliques merge. This merging interestingly results in one major clique with several other 
minor cliques. We then determined how much each clique grouping’s spatial and temporal 
distances deviated from a null model generated with 10000 permutations for that clique 
grouping (Figure 4.3.4). If isolates spread randomly on surfaces, we would expect z-
scores close to 0 for the spatial and temporal data. We projected the lowest z-score 
cutoffs onto the pairwise variant distances histogram (Figure 4.3.4). The greatest 
deviation from the null model for significant temporal (Figure 4.3.4) and spatial linkage 
(Figure 4.3.4) coincided with cutoffs that yielded the highest number of cliques. In this 
case, we found nine cliques for A. baumannii with both the time-minimizing distance and 
space-minimizing distance cutoff. For E. faecium, we found ten cliques for the time-
minimizing cutoff and 8 cliques for the space-minimizing cutoff. The cutoff values in that 
range best fit the radiation of isolates on these surfaces. After cutoff values increase 
beyond the clique-maximizing value, within-clique spatial and temporal distance 
observations rapidly increase to match and even exceed null estimations, indicating that 
the epidemiologically relevant variant cutoff was likely passed. 
For A. baumannii and for E. faecium, cliques are mostly restricted to single 
collection times, but some cliques, like clique 8 for A. baumannii, deviate from this trend 
and are instead broadly spread over surfaces in both time and space. Though most 
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cliques are restricted by time, cliques that are spread in time show room restricted 
patterning. This distribution of isolates could be explained by a reservoir of multiple clones 
with continual seeding to surfaces. In this scenario, most seeding events would not result 
in long-term surface, persistence, but a few clones could pass this strong filter to 
successfully survive for multiple weeks within rooms in a space dependent fashion. 




Figure 4.3.5 Genotypic antibiotic resistance in major species  
Resfinder results for A. baumannii (a), K. pneumoniae (b), E. faecium (c), P. aeruginosa (d). 
Resistance genes are grouped by antibiotic class on the y-axis and individual isolates are 
hierarchically clustered by their resistance genes on the x-axis. Black squares indicate the 
presence of a specific resistance gene in an isolate. Colored annotations are added next to the 
resistance genes for resistance gene class and above the charts for hierBAPS lineage (identified in 
Fig. 3 by branch color), week, surface, and room 
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 We used ResFinder to identify ARGs in draft genomes of our sequenced A. 
baumannii, E. faecium, K. pneumoniae, and P. aeruginosa isolates(35). Additionally, we 
determined if these isolates were phenotypically resistant, intermediate, or susceptible 
using Kirby-Bauer disk diffusion assays in accordance with Clinical and Laboratory 
Standards Institute (CLSI) guidelines(36). For all species, we found hierarchical clustering 
of isolates based on ARG presence or phenotypic susceptibility indicated lineage was the 
major predictor of resistance-based clustering patterns. Specific lineages can dominate 
clinical infections and tight correlation of lineage with resistance may relate to this 
phenomenon(37). This linkage between lineage and antimicrobial resistance may also 
allow for rapid, sequence based rather than gene-based susceptibility predictions(38). 
 A. baumannii isolates harbored 30 unique ARGs against 9 different classes of 
antimicrobials (Figure 4.3.5a). 40% (12/30) of these ARGs were β-lactamases and 26.7% 
(8/30) were expected to confer phenotypic resistance against aminoglycosides (Figure 
4.3.5a). 100% (65/65) of lineage 7 PAK-H isolates harbored blaOXA-23 and 95.4% (62/65) 
also had blaOXA-66, while none (0/4) of the USA-H isolates had either of these 
carbapenemases. Interestingly, USA-H isolates clustered close together with most other 
lineage 7 PAK-H samples rather than as a separate group (Figure 4.3.5a). 92.3% (72/78) 
of the bacteria were resistant to 3 or more classes of antimicrobials including two 
carbapenems. 4.05% (3/74) of the PAK-H A. baumannii isolates were resistant to all 14 
antimicrobials tested. Minocycline was most efficacious against PAK-H strains, with 
92.3% (72/78) non-resistant. 
 E. faecium isolates had 20 unique resistance genes against 7 classes of 
antimicrobials (Figure 4.3.5a). Only erm(A) was unique to a single isolate. Components 
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of the vanA operon and the macrolide ARG msr(C) were common to all isolates. As 
expected for vanA containing E. faecium, all isolates were resistant to vancomycin. 42.1% 
(24/57) were additionally resistant to chloramphenicol and doxycycline. All isolates were 
susceptible to daptomycin. 
 The K. pneumoniae isolates harbored 44 unique resistance genes and of these, 
25.0% (11/44) were unique to single isolates (Figure 4.3.5c). 3 blaNDM (blaNDM-1, blaNDM-5, 
and blaNDM-7) and 2 blaOXA (blaOXA-181 and blaOXA-232) carbapenemase genes were 
identified. blaNDM-5 was found in K. pneumoniae on 10 surfaces and in all 4 PAK-H ICU 
rooms. 39.4% (13/33) of K. pneumoniae isolates were resistant to meropenem and 
imipenem. 100% of lineage 1 (5/5) and lineage 2 (5/5) isolates and 60% (3/5) of lineage 
3 isolates were susceptible to these two antibiotics. All (33/33) isolates harbored the 
fosfomycin ARG fosA and an efflux pump component oqxA, however all lineage 4 isolates 
lacked the second component, oqxB. 
 P. aeruginosa isolates harbored 15 unique resistance genes against 6 classes of 
antimicrobials. All isolates had aph(3’)-lb, blaPAO, blaOXA-50, fosA, and catB7 (Figure 4.3.5). 
50% (3/6) of lineage 3 genomes had the carbapenemase blaGES-5. All lineage 4 P. 
aeruginosa isolates and 3/5 lineage 1 isolates were pan-susceptible to antibiotics. In 
contrast, all (8/8) lineage 2 and 3 isolates were resistant to meropenem, ciprofloxacin, 
and gentamicin. Our results demonstrate that the major abundant HAI pathogens contain 
a high ARG burden and exhibit profound levels of multidrug resistance. Infections from 
these bacteria could have limited treatment options due to high phenotypic multidrug 
resistance. 






 Given the extensive diversity and burden of high-risk ARGs found in A. baumannii, 
E. faecium, K. pneumoniae, and P. aeruginosa, we analyzed potential lateral transfer of 
ARGs between all collected species. To accomplish this, we concatenated identified 
acquired ARGs within each species and created a network diagram connecting each taxa 
with its ARGs (Figure 4.3.6a). The high connectivity of this network highlights the 
extensive promiscuity of ARGs we observe in these data. Strikingly, 57 ARGs were found 
in 2 or more species. These genes were expected to confer resistance against all classes 
of antibiotics, excluding vancomycin. E. faecium contained the macrolide resistance gene 
erm(B), which was also shared with E. coli. Given that E. faecium is the sole gram-positive 
species in this collection, it unsurprisingly had the most species specific ARGs (n=17). 
Sul1 was the most promiscuous ARG within our cohort, as it was identified in 22 different 
species, including those in Acinetobacter, Achromobacter, Alcaligenes, Atlanibacter, 
Citrobacter, Escherichia, Enterobacter, Klebsiella, Ochrobactrum, Pseudomonas, 
Providencia, Shewanella, and Superficieibacter. β-lactam ARGs were the most abundant 
class in our cohort, with a total of 57 identified from all 4 Ambler classes. Alarmingly, 
40.3% (23/57) of these genes have putative carbapenemase activity. blaGES-5 is the only 
Ambler Class A carbapenemase. 34.7% (8/23) of genes we identified are Ambler Class 
B Metallo-β-lactamases, from the blaVIM, blaIMP, blaEBR, blaDIM and blaNDM families. The 
Figure 4.3.6 Shared antibiotic resistance genes across diverse taxonomic groups 
 a Species and resistance gene network diagram. Species are represented as rectangles colored by family. 
Resistance genes are represented by ovals colored by resistance gene class. Lines colored by species family 
are drawn from each species to all the resistance genes annotated by Resfinder in that species 
isolates. b Annotated blaNDM-1 contigs in 11 isolates. Protein annotations colored by putative function are shown 
as arrows for each isolate’s blaNDM-1 contig. BLAST similarity values greater than 98% between contigs are shown 
in blue if they are oriented in the forward direction and red if they are oriented in the reverse direction. Species 




remaining 60.8% (14/23) were blaOXA variants including the blaOXA-48-like family members 
blaOXA-181 and blaOXA-232. blaNDM-1 showed the greatest diversity of host species, as it was 
identified 11 times in 10 different species from Alcaligenaceae, Enterobacteriaceae, 
Moraxellaceae, and Shewanellaceae.  
 blaNDM is a globally proliferated family of carbapenem resistance genes endemic to 
India and Pakistan (39). To better understand the local genetic context of blaNDM-1, we 
performed long-read sequencing with the Oxford NanoPore MinION platform on all 
blaNDM-1 positive isolates (Figure 4.3.6b). blaNDM-1 in all genetic contexts was adjacent to 
ble, a bleomycin resistance gene. The blaNDM-1 loci region was nearly identical between 
A. junii AJ_068/A. lwoffii AL_065/A. variabilis AV_175 and A. junii AJ_351/C. freundii 
CF_324, E. hormaechei EH_316, and S. putrefaciens SA70. A. junii AJ_351, C. freundii 
CF_324, E. hormaechei EH_316, and S. putrefaciens SA70 additionally contained blaOXA-
10 and ant1. A. junii AJ_068, A. lwoffii AL_065, and A. variabilis AV_175 had a different 
aminoglycoside resistance gene, aph. A. johnsonii AJ_082 contained the only rifamycin 
resistance gene, arr3. A. junii AJ_351, C. freundii CF_324, E. hormaechei EH_316, and 
S. putrefaciens SA70 also contained the emrE multidrug resistance transporter. On 
72.7% (8/11) of the loci, blaNDM-1 was co-localized with a transposase associated gene. 
Our analysis of ARG content across species identified high interconnectivity between 
most gram-negative species and determined blaNDM-1 is situated in similar genetic 
contexts across diverse taxonomic groups, suggesting extensive horizontal ARG transfer. 




Figure 4.3.7 Synergistic biofilm interactions for A. baumannii and E. faecium predicted by 
surface collections 
Permutation test of co-association between A. baumannii and E. faecium on surfaces conducted 
using species a absolute counts and b relative species frequencies. The expected distribution of 
the number of co-occurrences is shown in red and the observed number of co-occurrences in the 
dataset is shown as a vertical blue line. Total crystal violet stained c biofilm biomass and d XTT 
reduction for A. baumannii and E. faecium model biofilm strains grown in single and in co-culture 
(P-values were generated using unpaired, nonparametric Mann–Whitney statistical tests are 
indicated using the following mapping: **<0.01, ***<0.001, ****<0.0001). y-Axis for both plots is 
optical density at 590 nm and 450 nm, respectively, and error bars are 1 standard deviation. 
Synergy scores of dual vs single strain cultures for e biofilm biomass and f viable cells.  
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Bacteria harboring diverse ARGs may be recalcitrant to treatment regimens and 
could continually transmit from patients onto ICU surfaces, likely forming sessile biofilms 
to survive the dry conditions(40, 41). Indeed, biofilms composed of MDROs have been 
previously demonstrated to contaminate 93% (41/44) of hospital surfaces surveyed(23). 
To assay potential microbe-microbe interactions that may explain long-term surface 
persistence, we examined co-occurrences between abundant species in first three 
collection months using permutation testing. To remove potential bias from 
overrepresentation of certain taxa, we performed this analysis with both total counts and 
relative frequency. Both metrics demonstrated A. baumannii and E. faecium co-occurred 
on surfaces more often than predicted by chance (P < 0.00001 for A. baumannii and P = 
0.0083 for E. faecium [permutation test]) (Figure 4.3.7ab). 
 We then obtained isogenic strains of E. faecium (TX82/TX5645) and A. baumannii 
(ATCC-17978, 17978 ΔpgI) capable of or deficient in biofilm formation, respectively(42, 
43). Using every pairwise combination between the different species, we found co-culture 
of E. faecium TX82 with A. baumannii ATCC-17978 or A. baumannii 17978Δpgl, and E. 
faecium TX5645 with A. baumannii ATCC-17978 resulted in statistically significant 
increases (P < 0.0001 [Mann-Whitney U test]) in biofilm biomass relative to either of the 
parent strains (Figure 4.3.7b). This effect did not occur when both species were incapable 
of forming biofilms individually (Figure 4.3.7e).  
 As dead cells may be included in total analysis of biofilm biomass, we next 
specifically quantified the population of total viable cells between each pairwise 
interaction. Like results for total biofilm biomass, the number of viable cells increased 
significantly in E. faecium TX82/A. baumannii ATCC-17978 and E. faecium TX82/A. 
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baumannii 17978Δpgl compared to either parent strain (P < 0.0001 [Mann-Whitney U 
test]) (Figure 4.3.7d). However, in contrast to the increase in biofilm biomass observed 
for E. faecium TX5645/A. baumannii ATCC-17978 relative to both parent strains, we 
found a decrease in viable cells compared to A. baumannii ATCC-17978 (Figure 4.3.7f). 
Quantification of biofilm biomass synergy values between each strain combination shows 
all interactions except those between E. faecium TX5645 and A. baumannii 17978Δpgl 
are synergistic. For viable cells, interactions between E. faecium TX5645 and A. 
baumannii 17978Δpgl and A. baumannii ATCC-17978 versus E. faecium TX5645/A. 
baumannii 17978Δpgl are synergistic. These data suggest interspecies interactions 
between organisms identified on PAK-H ICU surfaces may enable increased survival due 
to synergistic growth inside biofilms. Importantly, relative efficacy of those interspecies 
biofilms depends strongly on individual strain capabilities. 
4.4 Discussion 
HAIs are a substantial patient health threat and economic burden(44). While pathogenic 
bacteria that often cause HAIs can be transferred via invasive medical procedures or 
directly between patients or healthcare providers, inanimate surfaces and shared 
equipment are also an important reservoir for bacterial transmission(14, 40). Here we 
report an in-depth, year-long investigation of bacterial colonization of hospital surfaces in 
two ICUs in Pakistan (PAK-H) and the USA (USA-H). We found substantially more 
contamination by MDROs on PAK-H surfaces compared to USA-H surfaces using 
identical differential and selective culture conditions.  
 In addition commonly recognized HAI causing bacteria, we found many potentially 
opportunistic pathogens and novel genomospecies from commonly pathogenic genera 
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(Pseudomonas, Stenotrophomonas, Brevundimonas). The first novel genomospecies 
from this collection to be fully characterized, S. electus, is a new genus of 
Enterobacteriaceae that harbored extended spectrum β-lactamases and was multidrug 
resistant(30). A previous taxonomic investigation determined that species from another 
novel genus of Enterobacteriaceae, Pseudocitrobacter faecalis and Pseudocitrobacter 
anthropi, harbored blaNDM-1 carbapenemases, and were identified in fecal samples from 
patients at hospitals in Pakistan(45). Currently no clinical evidence indicates these 3 
species are human pathogens, but it is concerning that they exist proximal to known 
pathogens, encode clinically-relevant ARGs, and are phenotypically resistant to multiple 
drugs. Furthermore, increasing implementation of WGS in clinical laboratories is enabling 
identification of emerging pathogens which were previously misidentified by traditional 
methods, such as the first report of a bloodstream infection by Kosakonia 
radicincitans(46). Our results provide additional utility for the implementation of WGS for 
bacterial delineation from clinically-relevant environments. Further comparative analysis 
and molecular and phenotypic evidence for pathogenesis is required to demonstrate that 
this level of identification is clinically relevant or actionable.  
 A. baumannii, E. faecium, K. pneumoniae, and P. aeruginosa, the 4 most abundant 
bacteria in our cohort, are also common pathogens and common HAI agents. 
Interestingly, through core-genome phylogenetic analysis we found that our A. baumannii 
and E. faecium isolates are dominated by single lineages, but K. pneumoniae and P. 
aeruginosa have nearly equal numbers of isolates from multiple lineages. Previous 
reports of K. pneumoniae and E. cloacae isolates from a US hospital system and Italy 
showed they were similarly composed of diverse sequence types(47, 48). Timepoint of 
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sample collection was the variable that showed greatest concordance with phylogenetic 
lineage. Lineage 7, the main group of A. baumannii isolates, was composed of several 
sequence types, including ST218, ST208, and ST195. These STs correspond to major 
strains collected of blaOXA-23 bearing A. baumannii in Indonesia; additionally, blaOXA-23 
positive ST195 isolates were responsible for an outbreak of infections in North China(49, 
50). The 4 ST208 USA-H A. baumannii isolates were genomically similar to the PAK-H 
isolates, although the PAK-H isolates harbored blaOXA-23 whereas the USA-H isolates 
have blaOXA-81. This parallels a previous investigation which found near identical genomes 
and plasmids from carbapenem resistant Enterobacteriaceae in the US and Pakistan, but 
US isolates exclusively contained blaKPC while blaNDM was only found in isolates from 
Pakistan(29). The most abundant E. faecium sequence type, ST132, was primarily 
contained in lineage 4. Isolates from this ST have been reported as both etiological urinary 
tract infection agents and as commensal animal bacteria(51, 52).  
 Though A. baumannii and E. faecium were dominated by a single lineage, we had 
evidence that the 6 clones of E. faecium came from all 4 lineages, but that 3/6 of the 
clones were from the dominant lineage 4 group. In contrast, all identified A. baumannii 
clones were in the dominant lineage 7. Given that clone 5 of E. faecium was found on 8/9 
timepoints during our collections, including the 0th and 52nd week, it is possible that PAK-
H surfaces are being colonized by a common seeding source or that these isolates 
represent the predominant clone circulating in the PAK-H region. Source investigation of 
carbapenemase producing organisms in a US hospital system determined that plasmids 
mobilizing the ARGs originated from building plumbing(53). As further evidence of this, 
we found that A. baumannii and E. faecium clones are more likely to co-localize in space 
90 
 
and time than if they were randomly distributed. This may have important clinical 
ramifications, as one analysis determined that although only 8.7% of ICU bacteria 
sequenced are from a clonal lineage, they were associated with clinical infection in 62% 
of occurrences(37). Therefore, eradication of the common contaminating source could 
drastically reduce spread of these clones and thereby reduce potential of spread to 
hospital patients. If bacteria are transmitting between surfaces, spatial and temporal 
linkage of these surfaces could mean effective decontamination of surfaces will have a 
combinatorial effect. 
 In our variant analysis, we identified that most cliques (complete subgraphs within 
the network where each node in the clique is connected to each other node in the clique) 
were time restricted, but a few cliques persisted across multiple collections. These 
persistent cliques subsequently showed room restriction. Several contamination routes 
could explain these results. For example, seeding bacteria may originate from patients 
occupying hospital rooms(54). Bacteria coming from different patients are likely 
genetically distinct in variant analysis; even within a patient, multiple lineages of the same 
species could co-exist(55). Seeding events from patient to surface would represent a 
bottleneck event and persistence on surfaces would represent another bottleneck. 
Bacteria passing the first bottleneck would be detected within a single collection time, and 
bacteria passing the second would be found in multiple collection times. Bacterial clones 
on many surfaces would have higher chances to spread to other surfaces in the same 
room or different rooms. Similar contamination patterns could also be observed due to 
water contamination in the hospital(53). PAK-H uses tap water with Virkon S disinfectant 
tablets (Lanxess) to clean hospital surfaces. If tap water has high bacteria burden or if not 
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enough tablets are used, the disinfectant protocol could contaminate rather than 
decontaminate surfaces. This tap water environmental source could contain a 
polymicrobial community, thus acting as reservoir for multiple bacterial lineages(56). With 
tap water, the first significant bottleneck would be getting from the water system to 
surfaces, but subsequent steps would be in line with the patient contamination scenario. 
In support of these potential contamination routes, the bacteria we observe in this study 
are a mixture of human fecal bacteria and water environmental bacteria(57, 58). This 
analysis demonstrates how a surface focused sampling and analysis approach can 
generate epidemiologically meaningful insights for future investigation. In our case, the 
hospital water system and ICU room patients can both be tested as potential reservoirs 
for observed ICU surface bacterial contaminants, and a longitudinal sampling scheme 
similar to the one used in our study would enable estimation of transmission dynamics 
between these putative contamination sources and sinks. 
 The A. baumannii, E. faecium, K. pneumoniae, and P. aeruginosa isolates we 
recovered from PAK-H surfaces had high ARG burdens and were often phenotypically 
resistant to multiple classes of antibiotics commonly used as treatment against them. This 
is particularly troublesome for local patient safety at PAK-H given that a retrospective 
cohort analysis found significant increases in 30-day mortality after infection when 
comparing patients infected by multidrug resistant versus susceptible organisms(59). 
Particularly problematic are the 3 A. baumannii isolates we recovered that were resistant 
to all antibiotics tested with CLSI interpretive criteria, similar to 20 pandrug-resistant 
isolates recovered from countries bordering the Mediterranean Sea(60). While we were 
unable to determine directionality of transfer, linkage analysis between acquired ARGs 
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and species harboring them show numerous instances of identical ARGs in different 
species. This is best exemplified by blaNDM-1 presence in 10 different species. Using long-
read nanopore sequencing, we found blaNDM-1 situated in a variety of genetic contexts, 
even between the two A. junii isolates that contained it. Similar to previous reports of 
blaNDM-1 in isolates recovered from Pakistan patient stool samples, the mobilization 
element ISAba125 was co-localized with blaNDM-1 in 4/11 of our isolates(61). Additionally, 
4/11 isolates also contained blaNDM-1 close to blaOXA-10, similar to numerous blaNDM-1 
harboring Enterobacteriaceae isolates from hospitalized patients(61). 
 Bacteria surviving in the built environment likely exist in sessile biofilms, which can 
make them difficult to eradicate(56). Numerous reports have determined dual or multi-
species biofilms have distinct characteristics to enhance survival and pathogenicity(62-
64). Direct sampling of ICU samples showed polymicrobial biofilms are widespread(23). 
Biofilm formation is an important component for pathogenesis of Enterococcus and 
Acinetobacter(65, 66). In both organisms, biofilm formation often requires extracellular 
attaching proteins including LH92_11085 and OmpA in A. baumannii or the Emp pilus in 
E. faecium(67-69). Variation has been observed among the ability of A. baumannii clinical 
isolates to form biofilms, but several strains are capable of growing on urinary catheter 
surfaces(70).  In E. faecium, adaption to a biofilm is associated with changes in the 
transcriptional program(71). 16S rRNA gene sequencing of high-touch surfaces at large 
public hospitals in Brazil identified both E. faecium and A. baumannii co-localized to the 
same surface(72). Despite this observation and the role of individual genes in biofilm 
formation for both species, there is a dearth of relative knowledge on specific interactions 
between these two species that may occur in the built environment. Our analysis of co-
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occurrence between organisms indicates A. baumannii and E. faecium isolates were 
cultured together more frequently than expected by chance. Additionally, we found co-
culture of model E. faecium and A. baumannii biofilm-forming and biofilm-deficient strains 
resulted in changes in total biofilm biomass and total viable cells dependent on the biofilm 
formation capacity of input strains. These results are consistent with a previous report on 
changes between Enterococcus faecalis and P. aeruginosa biofilms, where synergistic 
interactions between the exopolysaccharide produced by P. aeruginosa is responsible for 
spatial segregation of the two species in biofilms(73). It is therefore possible that 
conserved interspecies interactions between Enterococcus spp. and gram-negative 
nonfermenting bacteria may explain prolonged surface survival. 
 One limitation of our study is some bacterial species may be more robust than 
others in surviving on surfaces and in the sampling protocol. For example, bacteria could 
exist transiently between sampling times in concert on surfaces. However, the number of 
rare species we collected helps to allay this concern. We also did not concurrently 
characterize isolates recovered from clinical specimens. Therefore, we are unable to 
determine if lineages found on surfaces correlate with lineages associated with clinical 
infection in the hospital and in addition, we cannot corroborate linkage of lineages (e.g. 
P. aeruginosa in week 4) or clones (e.g. E. faecium clone 5) with time to determine if 
outbreaks occurred. Detailed analysis of clinical isolates may additionally inform 
associations of identified A. baumannii, E. faecium, K. pneumoniae, or P. aeruginosa 
lineages with specific infection niches and elucidate novel virulence factors or identify 
contaminated medical equipment. Additionally, samples of patient/healthcare workers 
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skin, stool, or oral microbiota, or of the room plumbing system could be used to further 
track transmission of the recovered MDROs to a specific source.  
 Our work represents a thorough longitudinal analysis of hospital surface 
contamination in Pakistan. We unequivocally demonstrate that MDRO burden is higher 
on PAK-H surfaces than on analogous USA-H surfaces. Using WGS we found that while 
the recognized human pathogens A. baumannii, E. faecium, K. pneumoniae, and P. 
aeruginosa are the most abundant organisms, a variety of potentially pathogenic taxa and 
novel genomospecies were also recovered. Analysis of lineages in the 4 most abundant 
species and clones in A. baumannii and E. faecium provide evidence of a common point 
source of contamination. Particularly alarming is our determination that these isolates 
harbor a high burden of ARGs, are often phenotypically multidrug resistant, and that 
identical ARGs are housed on a variety of genetic platforms in multiple species. 
Synergistic growth of E. faecium and A. baumannii in dual species biofilms may explain 
statistically significant co-occurrence on PAK-H surfaces. Complex ecology revealed by 
our hospital sampling highlights that common human pathogens and rare species 
frequently colocalize and share clinically relevant genes. Rapid dissemination of bacterial 
pathogens and plasmid borne ARGs stress importance of surveilling bacterial isolates in 
high-risk areas to protect vulnerable hospitalized patients around the globe. 
4.5 Materials and Methods 
4.5.1 Sample collection and culturing 
Intensive care unit rooms were sampled every other week for three months and then at 
six months and one year after the initial sampling. At each time point, five surfaces were 
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sampled in each patient room (if available in that room): the nursing call button (sampled 
the call button that is attached to the right of the bedside rail, swabbing as much of the 
surface as possible), the bedside rail (swabbing approximately 6 inches of the rail, 
swabbing the side that is closest to the room door), the main room light switch (swabbing 
the entire switch and switch plate), the sink handles (swabbing the handles on the sink 
inside the patient room, swabbing both handles, front and back), the alcohol hand foam 
dispenser (swabbing the one closest to the patient room, swabbing the high touch area 
of the dispenser). If a bedpan, commode or toilet was present in the patient room, this 
was also sampled, including the seat and handle. The Eswab collection and transport 
system (Copan, Murieta, CA) was used to collect all specimens; swabs were moistened 
prior to sample collection. Two swabs were held together for specimen collection. 
Specimens collected in Pakistan were shipped to the US site for workup and analysis.  
 One Eswab specimen was vortexed and 90 µL of eluate was inoculated to each of 
the following culture medium: Sheep's blood agar (Hardy Diagnostics), MacConkey agar 
(Hardy Diagnostics), VRE chromID (bioMerieux), Spectra MRSA (Remel), HardyCHROM 
ESBL (Hardy), Pseudo agar (Hardy), and MacConkey agar with cefotaxime (Hardy). 
Plates were incubated at 35 °C in an air incubator and incubated up to 48 hours prior to 
discard if no growth. Up to 4 colonies of each colony morphotype (as appropriate for the 
agar type) were subcultured and identified using MALDI-TOF MS with the VITEK MS 
system(74-78). A second Eswab specimen was used for Clostridium difficile culture with 
a heat-shock broth enrichment method as previously described(79). All isolates recovered 
were stored at -80 °C in TSB with glycerol. 
4.5.2 Antibiotic susceptibility testing 
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Antimicrobial susceptibility testing was performed using Kirby Bauer disk diffusion, 
interpreted according to CLSI standards(36). 
4.5.3 Illumina Whole Genome Sequencing 
Unique colony morphotypes from the initial swab plates were streaked for isolation on 
blood agar. After a culture was deemed pure by visual determination, ~10 colonies were 
suspended in deionized water with a sterile cotton swab. Total genomic DNA was 
extracted from the suspension using the bacteremia kit (Qiagen, Germantown, MD, USA). 
DNA was quantified with the Quant-iT PicoGreen dsDNA assay (Thermo Fisher Scientific, 
Waltham, MA, USA) .5 ng/ul of DNA was used as input for Illumina sequencing libraries 
with the nextera kit (Illumina, San Diego, CA, USA)(80). The libraries were pooled and 
sequenced on a NextSeq HighOutput platform (Illumina) to obtain 2x150 bp reads. The 
reads were demultiplexed by barcode, had adapters removed with Trimmomatic v.36, and 
contaminating sequences with Deconseq v.4.3(81, 82). Processed reads were 
assembled into draft genomes using the de-novo assembler SPAdes v3.11.0(83). The 
scaffolds.fasta files were used for all downstream analysis. Assembly statistics on the 
assemblies was quantified using QUAST v4.5(84). Prokka v1.12 was ran on the scaffolds 
file to identify open reading frames > 500 bp in length(31). 
For the 11 isolates chosen to be sequenced with Nanopore technology, Genomic DNA 
was extracted using the Genomic-Tip 500/G (Qiagen) and genomic DNA buffer set 
(Qiagen) per manufactures instructions. The DNA was converted into a sequencing 
library on with the Rapid Barcoding Kit (Nanopore, Cambridge, MA, USA) per 
manufactures instructions and sequenced on the MinION platform. The output fastq files 
were used in a hybrid assembly with SPAdes v3.11.0 and processed Illumina reads. 
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These assemblies are uploaded to NCBI under BioProject: PRJNA497126. 
4.5.4 Taxonomic assignment 
All isolates were initially identified using the VITEK MS MALDI-TOF MS v2.3.3. Following 
draft genome assembly, the species determination for all isolates were then investigated 
using an in silico approach. MASH was performed against all of the isolate genomes(85). 
Isolates that had 100% concordance between the MALDI-TOF MS assignment and the 
top 10 MASH hits were determined to be the species assigned by MALDI-TOF MS. 
Isolates that had discrepant analysis were then manually investigated further, by using 
RNAmmer v1.2 to identify the 16S rRNA sequence, submission of that sequence to the 
EZ BIoCloud taxonomic database, and finally ANI analysis with the mummer method 
between the isolate in question and the appropriate type genome (if available) using the 
JSpecies webserver (http://jspecies.ribohost.com/jspeciesws)(86-88). Species were 
determined if the genome in question had > 95% ANIm with the type genome (if 
available), or > 99% 16S rRNA identity (if type genome is not available)(89, 90). Isolates 
that did not pass either of these thresholds are therefore considered to be novel 
genomospecies. Finally, all the isolates sequenced in this study were used to construct a 
Hadamard matrix, representing the product of the average nucleotide identity and percent 
genome aligned, with the ANIm method from pyANI 
(https://github.com/widdowquinn/pyani). The matrix was visualized using the python 
package Seaborn (http://seaborn.pydata.org) and annotated for initial MALDI-TOF MS 
identification, and in silico assignment if discrepancies were identified.  
4.5.5 Core genome alignment 
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The gff files produced from Prokka for A. baumannii, E. faecium, K. pneumoniae, and P. 
aeruginosa were used to construct a core-genome alignment with Roary v3.8.0 and 
PRANK v1.0(32, 91). fastGEAR was ran on the respective core_genome_alignment.aln 
output of Roary to identify instances of recombination within these species(34). The 
recombinant regions were removed using custom python scripts. The recombination 
purged core genome alignment was used to generate a maximum likelihood tree with 
RAxML v8.2.11(33). The output newick file was visualized in iTOL. In silico multilocus 
sequence typing (MLST) was performed with the MLST program. The sequence type 
information, week of collection, room of collection, and surface was viewed as a color 
strip in iTOL(92). Lineages identified by hierBAPS during fastGEAR were also marked on 
the trees(93). 
4.5.6 Clonality analysis 
Pairwise SNP counts between all isolates in the recombinant corrected core genome 
alignment were calculated. All paired distances greater than 5 SNPs were excluded from 
further clonality analysis. Pairwise groupings with 5 or fewer SNPs were imported to 
Gephi as an unweighted pairwise links table. Gephi’s built in modularity analysis was used 
to isolate perfectly reciprocal groupings. R was used to visualize these groupings. 
Pairwise SNP distances were calculated as the number of SNPs between two isolates 
divided by the total number of positions in the core genome alignment. 
4.5.7 Calculate temporal and spatial distances for variant cliques 
Spatial and temporal analysis for variant distance for variant cliques used the same 
distances as core genome SNP linkage analysis. Spatiotemporal linkage analysis was 
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conducted for isolates in the first 3 months of collection. For each cutoff value, observed 
distances were calculated by adding together the spatial or temporal distances within 
clique and expected distributions were calculated by conducting 10,000 permutations of 
the spatial and temporal distances using the sample function in R v3.53. Thus, 
permutations kept clique structure, but shuffled distance information. 
4.5.8 ARG identification 
Acquired ARGs against aminoglycosides, amphenicols, β-lactam, folate pathway 
inhibitors, fosfomycin, macrolides/lincosamides/streptogramins, quinolones, rifamycin, 
tetracycline, vancomycin were annotated using the ResFinder BLAST identification 
program(35). For the abundant species, the presence/absence matrix of ARGs was 
visualized in pheatmap (R). Associated metadata was displayed as a color strip to 
represent bacterial isolate demographics and expected resistance to antibiotics. To 
identify connectivity between the recovered species from the Pakistan ICU, we 
constructed a Source/Target/Edge formatted file, where each source represented a novel 
or curated genomospecies, a target was the unique ARG, and Edge weight was 
determined to be the number of times that ARG was identified within that species. The 
file was visualized in Cytoscape v3.4.0(95). 
4.5.9 blaNDM-1 loci annotation and comparison 
A ~6-2kB series of nucleotides flanking the blaNDM-1 loci in all positive strains was 
manually retrieved from SPAdes output of MinION & Illumina hybrid assembly. The 
nucleotides were re-annotated with prokka. The .gff file was used as input for Roary, to 
identify identical genes within the loci pan-genome. The .gbk files from prokka were 
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viewed for open reading frames and BLAST similarity in EasyFig(96). The sequences 
were ordered by their relationship from the newick tree created from the 
presence/absence matrix of genes. All loci in the pan-genome were submitted to BLASTX 
against the refseq_proteins in October 2017 to identify a putative function(97). The 
pairwise BLAST similarity was visualized on the EasyFig v2.2.2 construction by BLASTN 
similarity between the fasta files.  
4.5.10 A. baumannii and E. faecium co-association permutation testing 
Testing for significant association of A. baumannii and E. faecium was conducted using 
MALDI-TOF MS identifications from the first 3 months of PAK-H collections. The number 
and type of unique bacteria on each surface was tabulated. The number of surfaces with 
both A. baumannii and E. faecium was recorded as the observed frequency of co-
occurrence. Absolute number and relative frequency expected distributions for A. 
baumannii and E. faecium co-occurrence were calculated using permutation tests with 
10,000 random subsamples. For absolute number, the exact number of each bacterial 
species we collected was randomly distributed to a blank surface space with the 
restriction that each surface could not have more than one of the same species and that 
each surface had to get the same number of bacteria that was originally collected from 
the surface. This resulted a new permuted collection space with the same overall number 
of each bacterial species, but with randomized placement for each bacterium. The co-
occurrence of A. baumannii and E. faecium for this permuted collection space was then 
recorded for the expected distribution. For relative frequency, the number of each species 
collected was used to calculate the frequency of that bacterial species in the collections. 
During permutation species were randomly chosen, weighted by their frequency in the 
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collections. R was used to visualize the A. baumannii and E. faecium co-association 
expected distributions and observed values. 
4.5.11 Biofilm assays 
Frozen cultures of A. baumannii ATCC-17978 (17978), A. baumannii ATCC-17978Δpgl, 
E. faecium TX82, and E. faecium TX5645 were streaked onto tryptic soy agar (Difco, 
Detroit, MI, USA) and grown overnight at 37 C. Isolated colonies were suspended in 
tryptic soy broth (Difco, Detroit, MI, USA) supplemented with .5% glucose (MP 
Biomedicals, Santa Ana, CA, USA) to promote the growth of E. faecium biofilm and 
quantified for OD600 using a 1:10 dilution. In concordance with previous investigations 
using respective strains, the A. baumannii isolates were normalized to .05 OD600 and 
the E. faecium were normalized to .10 OD600. For functional assays.  
To grow biofilms, 200 μl of each single strain or 100 μl of A. baumannii and 100 μl of E. 
faecium dual species biofilms were added to tissue culture treated 96 well polystyrene 
microtiter plates (Sigma Aldrich, St. Louis, MO, USA) in triplicate. We additionally plated 
cell-free controls to ensure that no contamination occurred and to subtract out 
background absorbance reading. After pipetting, the plates were gently pipetted up and 
down to ensure that the strains mixed thoroughly. The plates were covered with breath 
ez membrane (Diversified Biotech, Dedham, MA, USA) and grown on the benchtop at 
approximately 22 Celsius for 16 hours. 
Following a growth period, the biofilm plates had planktonic cells removed by washing 
thoroughly with 250 μl sterile phosphate buffered saline (PBS) (Thermo Fisher Scientific, 
Waltham, MA, USA) three times. To obtain the total biofilm biomass, the washed biofilms 
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were fixed with 250 μl bouin's solution (Sigma Aldrich) at 22 ° Celsius on the benchtop 
for 30 minutes. The fixative was washed three times with 200 μl sterile PBS three times 
and then stained with 250 μl .01% crystal violet (Sigma Aldrich) in water for 30 minutes 
at 22 °Celsius on the bench. Finally, the unstained crystal violet was removed by washing 
three times with PBS and then the biomass was solubilized with 250 μl of 100% ethanol 
(Sigma Aldrich). The amount of biofilm biomass was quantified using nm absorbance with 
a Synergy H1(BioTek) spectrophotometry machine. All raw absorbance values were 
adjusted by removing the background values obtained from the cell-free TSB controls. 
The conditions had average and standard deviation calculated. 
For quantification of total viable cells in the biofilm, the biofilms were formed as previously 
described. After 16 hours growth at 22 ° Celsius, planktonic cells were removed by 
washing thoroughly with 250 μl PBS. The XTT cell viability kit (Cell Signaling 
Technologies, Danvers, MA, USA) was then performed according to manufacturer’s 
instructions. The plates were read in the Synergy H1 spectrophotometry machine after 5-
hour incubation in the dark. 
For the crystal violet and XTT reduction assays, the biofilm synergy scores were 
calculated as previously reported for dual species biofilms. For each pairwise comparison, 
the synergy scores were reported as the difference between the average plus standard 
deviation for the single species biofilm and average minus standard deviation of the dual 
species biofilm. 
(1) Biofilm synergy = (AverageDualSpecies – Standard DeviationDualSpecies) – 




Unpaired, nonparametric Mann Whitney statistical tests were used to compare the 
adjusted OD590 and OD450 values between the total biofilm biomass and total viable cells 
in the dual vs single species biofilms. 
4.5.13 Data availability 
Assemblies are available from NCBI under BioProject: PRJNA497126. 
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Chapter 5: In silico analysis of Gardnerella genomospecies detected in the setting 
of bacterial vaginosis 
5.1 Abstract 
Gardnerella vaginalis is implicated as one of the causative agents of bacterial vaginosis, 
but it can also be isolated from the vagina of healthy women. Previous efforts to study 
G. vaginalis identified 4-6 clades but average nucleotide identity analysis indicates that 
G. vaginalis may be multiple species. Recently, Gardnerella was determined to be 13 
genomospecies, with Gardnerella piottii, Gardnerella leopoldii, and Gardnerella 
swidsinkii delineated as separate species. We accessed 103 publicly available 
genomes annotated as G. vaginalis. We performed comprehensive taxonomic and 
phylogenomic analysis to quantify the number of species called G. vaginalis, the 
similarity of their core-genes, and their burden of their accessory genes. We additionally 
analyzed publicly available metatranscriptomic datasets of bacterial vaginosis to 
determine if the newly delineated genomospecies are present, and to identify putative 
conserved features of Gardnerella pathogenesis. Gardnerella could be classified into 8-
14 genomospecies depending on the in silico classification tools used. Consensus 
classification identified nine different Gardnerella genomospecies, here annotated as 
GS01-GS09. The genomospecies could be readily distinguished by the phylogeny of 
their shared genes and burden of accessory genes. All of the new genomospecies were 
identified in metatranscriptomes of bacterial vaginosis. Multiple Gardnerella 
genomospecies operating in isolation or in concert with one another may be responsible 
for bacterial vaginosis. These results have important implications for future efforts to 
understand the evolution of the Gardnerella genomospecies, host-pathogen interactions 
125 
 
of the genomospecies during bacterial vaginosis, diagnostic assay development for 
bacterial vaginosis, and metagenomic investigations of the vaginal microbiota.  
5.2 Introduction 
Bacterial vaginosis (BV) is a common infectious disease of women, often caused by 
Gardnerella vaginalis (1, 2). However, G. vaginalis has also been identified in healthy 
women without BV (3, 4). One explanation is that certain strains of G. vaginalis are 
more pathogenic than others. Genome-based taxonomic methods, which have 
delineated novel species in other genera, have scarcely been applied to G. vaginalis. 
Importantly, one recent investigation found that average nucleotide identity (ANI) values 
between different G. vaginalis subgroups were below the species cutoff of 96%, 
indicating G. vaginalis may be multiple species (5). Recently, using ANI and digital 
DNA-DNA hybridization assays, it was found that 13 different Gardnerella 
genomospecies may currently be annotated as G. vaginalis (6). Three of these species 
were fully elucidated using phenotypic assays and termed Gardnerella piotii, 
Gardnerella leopoldii, and Gardnerella swidsinkii (7).  
Historically, delineation of new bacteria taxa has relied on phenotypic differences 
between strains such as chemical analysis or biochemical utilization characteristics, 
with the laborious DNA-DNA hybridization assay representing the gold standard 
analysis for species-level determination (7). Using 16S rRNA gene sequencing, a cut off 
of 97% is typically used to delineate bacteria, but given that recognized different species 
can have values greater than 97% similarity, whole-genome data such as ANI are often 
also used (7, 8). ANI values ≥96% are used as thresholds for species-level designations 
(9). In the absence of an isolated organism, putative novel species can be determined 
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by genetic content alone but are termed genomospecies. In addition, recognized 
species can also be re-classified such as Escherichia hermannii and Salmonella 
subterranea to Atlantibacter hermannii and Atlantibacter subterranea, respectively (10). 
Given the previous analysis on Gardnerella, we used multiple in silico taxonomic 
classification tools to bin publicly available Gardnerella genomes into different 
genomospecies and then performed comparative analysis between the genomospecies.  
To address the knowledge gap regarding the taxonomic diversity and relatedness within 
genomes currently classified as G. vaginalis, we performed a retrospective comparative 
analysis using 103 publicly available genomes as well as BV metatranscriptomes. 
Based on the observation that multiple G. vaginalis genomes may be related by ANI 
values less than the species cut-off of 96%, we hypothesized that multiple distinct 
genomospecies have been collapsed into a single G. vaginalis species annotation. 
Further, we hypothesized that these genomospecies could be    distinguished by the 
relatedness of their shared genes and the differential burden of their accessory genes.  
5.3 Results 





Figure 5.3.1 Different in silico taxonomic tools produce 8-14 Gardnerella genomospecies  
Heatmaps with hierarchal clustering of the pairwise values for JSpeciesWS ANIb (A), JSpeciesWS 
tetranucleotide frequency (B), Kostas Lab ANI (C), and Kostas Lab AAI (D) for the 14 
representative Gardnerella strains. All strains are assigned a numerical identifier. Red lines in the 
clustering pattern indicate groups of 2 or more genomes that represent the same genomospecies 
for that tool. The ANI (A & C) and AAI (D) plots are colored so that the taxonomic cutoff of 96% or 
90% respectively are white. Pairwise values above this cutoff in the red spectrum and values 
below in the blue spectrum.  
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We began analysis by using pyANI with the mummer nucleotide alignment method to 
determine pairwise ANI values between the 103 genomes obtained from NBCI. This 
analysis indicated that in addition to the 13 genomospecies delineated by Vaneechoutte 
et al (6), strain NR010 may represent a 14th genomospecies as it did not have any ANI 
values >96% to any other genome. From this we found that Gardnerella may contain a 
maximum of 14 genomospecies. We then used multiple publicly available tools for 
verification. Therefore, to further assess if genomes annotated as the species G. 
vaginalis represent multiple genomospecies, we used two additional different ANI 
platforms, tetranucleotide frequency, and AAI tools to delineate the genomes into 
genomospecies (9, 14, 29, 30). We chose 13 genomes from the recent delineation of G. 
vaginalis including the type genomes for G. vaginalis, G. piotii, G. leopoldii, and G. 
swidsinkii, as well as NR010 (6) (Table 1).Our results showed that the number of 
annotated genomospecies ranged from 8-14, depending on the classification tools 
employed (Figure 5.3.1). ANI with the BLAST nucleotide alignment method (ANIb) from 
JSpeciesWS indicated that these genomes represented 14 unique genomospecies 
(Figure 5.3.1A). In comparison, classification by tetranucleotide frequency from 
JSpeciesWS, found that the 14 genomes are 9 genomospecies (Figure 5.3.1B). 
Tetranucleotide frequency-based classification found that the type strains G. leopoliddi 
UGENT 06.41 (T) and G. swidsinkii GS 9838-1 (T) may be the same genomospecies. A 
separate ANI classifier (ANI calculator from the Kostas lab) indicated that the 14 
genomes instead represented 12 genomospecies, and again that the type strains G. 
leopoliddi UGENT 06.41 (T) and G. swidsinkii GS 9838-1 (T) may be the same 
genomospecies (Figure 5.3.1C). Finally, an AAI classifier (AAI calculator from the 
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Kostas lab) produced the most conservative estimate of the number of genomospecies, 
identifying 8 genomospecies from the 14 genomes (Figure 5.3.1D). The AAI 
classifications were concordant with the JSpeciesWS tetranucleotide frequency-based 
classifications in that G. vaginalis ATCC 14018 (T)/JCP8108, G. piotti UGENT 18.01 
(T)/JCP8017A, and UMB1686/6119V5/1500E were the same genomospecies, 
respectively. The AAI calculator was the only tool that considered GED7760B the same 
genomospecies as G. piotti UGENT 18.01 (T)/JCP8017A. 
We adopted a conservative consensus approach for genomospecies classification for 
the remainder of our analysis. Specifically, if two or more of the aforementioned tools 
indicated that the genomes represent the same genomospecies then we counted them 
as the same. This method had exact concordance with the tetranucleotide frequency 
tool classification and yielded nine Gardnerella genomospecies (GS01-GS09) (Table 
5.3.1). All comparative analyses and biological conclusions hereafter are based on 
these nine genomospecies. 
5.3.2 Core-genome alignment support relatedness of the genomospecies into 8 
clades 
To gain further insight into the taxonomic structure of the Gardnerella genus, we 
determined the 200 core-genes (the loci present in 100% of strains) at 70% nucleotide 
identity with the pan-genome tool Roary and aligned these genes with PRANK to create 
a core-gene alignment. We used FastTree to construct an approximate maximum 
likelihood tree from the core-genome alignment, which depicted the evolutionary 
relationship between all genomes analyzed and provided a confidence value for every 
branch point (Figure 5.3.2A). The tree had 100% bootstrap support values at the major 
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branch points, indicating a high degree of confidence on the relatedness of the 
Gardnerella genomospecies to one another. Midpoint rooting of the tree in iToL 
depicted a major spit within the genus between GS01/GS02/GS06 and 
GS03/GS04/GS05/GS07/GS08/GS09. Lineage identification using FastGear/BAPS on 
the core-genome alignment identified eight major lineages that had almost exact 
concordance with the consensus delineation into genomospecies, except that GS02 
and the single genome GED7760B (GS06) were determined to be in the same lineage 
(Figure 5.3.2A). FastGear initially assigns clusters with the BAPS software and then 
uses an additional allele comparison to produce more refined groups. The single 
genomes/genomospecies KA00225 (GS08) and NR010 (GS09) were counted as their 
own lineages, indicating that the allele frequencies between GS06 and GS02 may be 
similar enough compared to the background comparisons that they are linked into the 





As a second method to view the relatedness of the genomospecies, we visualized the 
core-genome alignment file as a nearest neighbor network in SplitsTrees (Figure 
5.3.2B). The clustering pattern of the isolates were visually concordant with the 
maximum likelihood tree. Importantly, the isolates from GS07 and GS08 deviated away 
Figure 5.3.2 Core-genome phylogenetic analysis shows the genomospecies fall 
into 9 distinct clusters 
(A) Approximate maximum likelihood phylogenetic tree from PRANK alignment of the 
200 core-genes identified by Roary with FastGear/BAPs lineages annotated adjacent 
to the tree. Groups of genomes that represent the same genomospecies identified by 
the conservative consensus approach are colored. (B) Nearest neighbor network of 
the core-genome alignment with genomospecies annotated as tip labels.  
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from the center of the network, providing additional evidence on their separation from 
the group containing GS03, GS04, GS05, and GS09 (Figure 5.3.2B). 
5.3.3 Gardnerella genomospecies have distinct accessory gene repertoires 
To understand the differential burden of accessory genes that may contribute to niche 
adaptation within the vaginal microenvironment and/or to BV pathology, we performed a 
principal component analysis on the presence/absence matrix of non-core genes 
identified by Roary. PERMANOVA using adonis2 from the vegan package in RStudio 
indicated that genomospecies and accessory genome composition were significantly (p 
<.00001) linked. Superposition of the genomospecies classification onto the principal 
component analysis plot demonstrated that the accessory gene content for GS04, 
GS05, and GS09 were remarkably similar but that there were large differences between 
the other genomospecies (Figure 5.3.3A). In particular, the three major genomospecies, 
GS01, GS02, and GS03 were situated in the periphery of the plot, demonstrating 







To gain insight into which genes may be driving this clustering pattern, we queried the 
pan-genome using the pan-genome association tool, Scoary, for genes that were 
differentially enriched within GS01, GS02, and GS03 (Figure 5.3.3B). For genes with 
putative function as sialidases, glycoside hydrolases, carbohydrate ATP-binding import 
protein, and allantoin metabolism, we viewed the presence/absence of the clusters in 
iTOL and quantified the gene burden in Prism. Interestingly, we found that genes 
annotated as sialidases were significantly (p<0.0001) enriched in GS02 over GS01 and 
GS04-GS09 (Figure 5.3.3C). These genes were completely absent from GS03 
genomes. Similarly, genes annotated as glycoside hydrolases and carbohydrate ATP-
binding import proteins were significantly (p<0.0001) enriched in GS01 (Figure 5.3.3C). 
Lastly, we found that genes involved in the uptake and usage of allantoin were enriched 
(p<0.0001) in GS03, absent in GS01 and GS02, and sparsely present in the other 
genomospecies (Figure 5.3.3C). To understand overall differences in metabolic 
potential between the genomospecies, we submitted the pan-genome reference fasta to 
Figure 5.3.3 Accessory gene burden is different between the major genomospecies 
(A) Principal component analysis of the accessory gene presence/absence matrix created by 
Roary with the genomes colored by their genomospecies. Each individual point represents 
the accessory gene content of a Gardnerella genome. Points closer to one another have 
similar accessory gene content. (B) Presence/absence matrix for accessory genes with 
putative sialidase, glycoside hydrolase, carbohydrate ATP-binding, and allantoin utilization 
roles adjacent to the phylogenetic tree from Figure 2A (distances not to scale) with 
genomospecies identity. Each filled square represents the presence of a given gene and a 
blank square represents the absence of that gene. Squares are colored based off predicted 
function. (C) Total counts for the number of genes identified with suspected function as 
sialidases, glycoside hydrolases/carbohydrate ATP-binding, and allantoin utilization abilities. 
Paired student T-test results are shown for all significantly different gene burdens between 
GS01, GS02, GS03, and GS04-09.  
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EggNOG for COG annotation and quantified the number of COGs present in each 
genomospecies. The results were remarkably similar across all COGS except a notable 
increase in genes related to “Carbohydrate transport and metabolism” in GS01. 
Similarly, GS01 had a significantly (p<0.0001) higher amount of carbohydrate utilization 
genes annotated by the CAZy database compared to the other genomospecies. In 
summary, we found that the different Gardnerella genomospecies could largely be 
distinguished by the presence/absence of their accessory genes and that accessory 
genes with specific functions were enriched or absent in certain genomospecies. These 
results indicated that different Gardnerella genomospecies had distinct gene 
repertories, which may lead to niche separation within the vaginal environment.  




Figure 5.3.4 Newly elucidated genomospecies are identified in BV metatranscriptome 
samples  
(A), Heatmap with hierarchal clustering from Centrifuge depicting the percentage of unique 
Gardnerella genomospecies-specific reads for each patient sample. Samples are labeled for 
clinical information related to efficacy of metronidazole treatment. Clusters of similar taxonomic 
profiles mentioned in the Results are labeled using roman numerals at the root of each cluster. 
(B), Stacked bar plots from Centrifuge showing the percentage of unique Gardnerella reads for 
each genomospecies within the metatranscriptome samples. 
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Metatranscriptomes are the genes that are expressed by a community of bacteria in any 
given environment. Given our improved resolution of Gardnerella into nine 
genomospecies, we wanted to investigate if any of the newly elucidated genomospecies 
could be identified in the metatranscriptomes of BV samples. To accomplish this, we 
used the short-read classifier Centrifuge, on metatranscriptome sequencing reads from 
BV samples of women before and after receipt of metronidazole therapy (26, 27). 
We used Centrifuge to identify the percentage of Gardnerella reads that uniquely map 
to just one of the genomospecies within BV metatranscriptome samples for all of the 
genomospecies (26, 27). Metatranscriptome reads mapping uniquely to only a single 
genomospecies were identified for all genomospecies but GS04, GS06, GS08, and 
GS09 had a mean presence of 1.74%, 1.0%, 0.49%, and 0.41% across all samples. As 
our classification scheme was designed specifically to focus only on the Gardnerella 
genomospecies, in 3 of 20 samples, the largest value of unique reads was unmapped. 
08_003_a had the largest number of Gardnerella specific unique reads, with only 
15.01% unmapped. Hierarchical clustering of the genomospecies percent values 
showed that clustering was primarily driven by taxonomic signatures, rather than 
treatment outcomes to metronidazole therapy (Figure 5.3.4A). Visual interpretation of 
the heatmap showed 4 primary clusters of similar taxonomic profiles.  
The first cluster containing only 08_003_a is largely dominated by a single 
genomospecies as 90.56% of the Gardnerella specific reads uniquely map to GS07 
(Figure 5.3.4B). The second cluster contains 06_006_a, 06_006_b, and 06_001_a, and 
are notable for their abundance of GS05 since it composes 91.79%, 84.20%, and 
83.89% of the Gardnerella specific reads in these samples (Figure 5.3.4B). The third 
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cluster contains 17_004_b, 08_006_a, and 05_012_a, and has high levels of GS02 
metatranscriptome unique reads at 79.95%, 70.93%, 46.29%, respectively (Figure 
5.3.4B). The fourth cluster containing 13 of 20 of the samples is notable for having the 
highest mean percent of GS01 (30.51%) and GS03 (46.18%). Unique reads for GS04 
had the greatest prevalence within this cluster as sample 13_019_a contains 29.15% of 
GS04 unique reads (Figure 5.3.4B). These results indicate that the newly elucidated 
Gardnerella genomospecies can be identified as major contributors to Gardnerella 
specific metatranscriptome reads during BV.  
5.3.5 Expression of translation machinery and putative virulence factors by 
Gardnerella during BV 
 
Since metatranscriptomes provide a snapshot of the genes that are being transcribed, 
we finally wanted to investigate conserved features of Gardnerella gene expression 
during BV. To accomplish this, we used PanPhlAn to quantify gene coverage values for 
every gene in the pan-genome matrix created by Roary and the EggNOG COG 
annotation to identify enriched functions within highly expressed genes (one standard 
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Figure 5.3.5 Gardnerella translation machinery and vaginolysin 
expression during BV  
(A), Enrichment index scores for the COGs from EggNOG of the 
top 224 expressed Gardnerella pan-genome genes. Scores >1 are 
considered significantly enriched and are depicted in black; 
nonenriched COGs identified within the top 224 expressed genes 
are in gray. (B), Pan-genome plot depicting each of the 7402 genes 
as the number of isolates that harbor that gene (x value) and the 
PanPhlAn gene coverage value (y axis). Genes mentioned in article 
text are shown in red. 
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translation (J), and protein turnover (O) were all enriched within the highly expressed 
genes (Figure 5.3.5A). The other evident pattern was that COGs for carbohydrate 
transport/metabolism (G) and energy production/conversion (C) were also enriched. 
Analysis of individual genes among the highly expressed group identified several 
candidates involved in BV pathogenesis, including the known vaginolysin toxin gene 
(ply) (Figure 5.3.5B) (31). Arguably the best studied pathogen in the Actinobacteria is 
Mycobacterium tuberculosis, and although M. tuberculosis and G. vaginalis exist in 
different human-associated environments, several of the highly expressed genes in BV 
transcriptomes are known virulence factors in the actinobacterial pathogen M. 
tuberculosis, suggesting a conserved importance in G. vaginalis (Figure 5.3.5B) (32-35). 
These include the transcriptional regulator carD, the trehalose import protein sugC, the 
glycan-branching enzyme glgB, and the oxidative stress response gene ahpC. cycB, a 
gene involved in maltose binding, was also found to be highly expressed, consistent 
with the importance of carbohydrate metabolism in the COG enrichment analysis (36). 
Additionally, we found that the lantibiotic lacticin gene, lctA, was not strongly conserved 
in the Gardnerella pan-genome, but was expressed at a high level (37). This data 
identifies several genetic loci which may be a conserved feature of Gardnerella 
pathogenesis in BV.  
5.4 Discussion 
In microbial taxonomy, phylogenomic methods are being utilized with increasing 
frequency to specifically and accurately delineate new bacterial species from several 
previously known genera, including commensal and pathogenic members of Klebsiella 
and Propionibacterium (22, 38). These delineations can have important implications in 
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understanding the biology and clinical significance of these closely-related organisms, 
and their potential differential contributions to health and disease in various hosts. For 
instance, although previously believed to be a benign environmental species, Klebsiella 
variicola strains can cause higher bladder infection titers in a mouse model of urinary 
tract infections compared to the canonical pathogen Klebsiella pneumoniae (39). 
Similarly, presence of gene clusters encoding ABC transporters and 
phosphotransferase systems were differentially present within different genera of 
cutaneous propionibacteria, which may enable adaptation of Cutibacteirum, 
Pseudopropionibacterium, and Acidipropionibacterium to different skin niches (38). Our 
goal was to use initial binning of Gardnerella genomes into genomospecies using a 
variety of available tools and then explore differences in phylogeny, gene content, and 
metatranscriptome presence to provide insights into the biology of Gardnerella during 
BV. 
Several previous reports have used whole-genome sequencing to compare pathogenic 
and commensal Gardnerella strains but did not systematically use taxonomic tools to 
define clear genomospecies (5, 40-42). An early analysis between strains 409-05 
(GS03), ATCC 14018 (GS01), and ATCC 14019 (GS01) found that 409-05 lacked 
mucin degrading sialidases (40). Our analysis corroborates this finding, since we did not 
identify any sialidases in GS03 genomes. A broader analysis of the core-genome 
similarity between 17 strains found that they could be classified into 4 separate clades 
(42). By applying taxonomic methods to compare 103 publicly available genomes 
annotated as G. vaginalis, we found exact concordance between these initial clades 
and our genomospecies, as Group-1 corresponds to GS01, Group-2 corresponds to 
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GS02, Group-3 corresponds to GS05, and Group-4 corresponds to GS03 (42). The 
differentiation of G. vaginalis into 4 clades had been recapitulated by alignment of just 
the cpn60 locus (5). Again, we found complete concordance between these earlier 
delineations and our genomospecies as the subgroup A isolates corresponding to 
GS03, subgroup B were GS02, subgroup C were GS01, and subgroup D were GS05. 
Importantly, this latter study used pairwise ANI analysis to determine that ANI values 
<95% were found between the cpn60 group designations, suggesting that they 
constituted separate genomospecies (5). One report on comparative analysis of 37 
Gardnerella isolates identified 6 clades based off of conserved gene similarity and 
distinct gene presence (43). This study, however, indicated that JCP8481A/JCP8481B 
(GS04) and 6119V4/00703Dmash (GS05) were both in clade 3A (43). Conversely, they 
suggested that JCP775/ATCC 14019 and 00703C2mash/JCP8070, GS01 and GS02 
respectively, were in separate clades (43).  
Recently, one analysis of 81 Gardnerella strains found that they represented 13 
genomospecies, 3 of which were elucidated to be the new species G. piotii, G. leopoldii, 
and G. swidsinkii, using a combination of in silico tools and phenotypic assays (6). This 
report did not include NR010, which was consistently annotated as a separate 
genomospecies in the 4 taxonomic tools that we used, making the current maximum 
number of Gardnerella genomospecies as 14. However, we show that for the type 
strains within G. vaginalis, G. piotii, G. leopoldii, G. swidsinkii, and representatives of 
the other 10 genomospecies, conflicting taxonomic information can arise from ANI vs 
tetranucleotide frequency vs AAI tool use (9, 29, 30). The greatest discrepancies were 
between the JSpeciesWS ANIb method (14 species) and the Kostas Lab AAI tool (8 
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genomospecies). For the purposes of our study, we took the conservative consensus 
for the number of genomospecies across the 4 tools, which had exact concordance with 
the tetranucleotide frequency analysis in JSpeciesWS. Strikingly, in 3 of 4 of the tools 
tested, the type strains G. leopoldii UGENT 06.41 (T) and G. swidsinkii GS 9838-1 (T) 
were annotated as being the same genomospecies, conflicting the phenotypic results 
(6). It is possible that these two strains may represent different subspecies of the same 
Gardnerella species. The approximate maximum likelihood tree and nearest neighbor 
network both showed that the genomospecies can be readily distinguished by the 
similarity of their 200 core-genes. Similarly, the genomospecies had vastly different 
repertories of accessory genomes, except the group that contained GS05, GS04, and 
GS09. These differences may be important for adaptation to the vaginal 
microenvironment or BV pathology since some of the genes driving this difference 
include those known for virulence (e.g., sialidases) (44, 45).  
Given that GS07 and GS04-GS09 were unknown in these prior genomic studies and 
that there was occasionally ambiguity between previous group determinations, we used 
metatranscriptome sequencing reads from BV samples from women before and after 
metronidazole, to determine if the Gardnerella genomospecies could be implicated in 
BV pathogenesis (12). Similar to the original study, our results did not find any 
association between the presence of specific Gardnerella genomospecies and 
resistance to metronidazole, even with the improved taxonomic classification (12). 
However, we detected unique transcripts to all genomospecies in every sample. When 
we combined the taxonomic information to identify conserved features of Gardnerella 
pathogenesis in BV, we found enrichment for COGs involved in carbohydrate transport 
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and conversion into energy as well as propagation of protein machinery. Importantly, 
the known virulence factor ply and several genes implicated in pathogenesis of the 
Actinobacteria M. tuberculosis were some of the genes with the highest coverage 
values. 
The major limitation of this investigation is that as a retrospective genomic analysis, we 
do not have immediate access to the isolates for species characterization. 
Comprehensive analysis of differences in membrane lipids and biochemical utilizations 
would be necessary to correctly classify these nine genomospecies into species, with 
proper Latin nomenclature (6). Another limitation relates to the fact that our analysis 
includes metatranscriptome reads rather than metagenomic reads, and thus we are 
unable to accurately quantify absolute abundance of the different genomospecies within 
the BV samples, since it is possible that a genomospecies could compose a smaller 
overall fraction but express a large number of genes.   
5.5 Materials and Methods 
5.5.1 Publicly available genomes and metatranscriptome reads 
4 genomes annotated as Gardnerella unclassified and 99 genomes annotated as G. 
vaginalis were retrieved from National Center for Biotechnology Information genomes in 
October 2018. The assembly file containing chromosome and plasmid components for 
all genomes were used for analysis. All genomes were re-annotated for open reading 
frames using prokka (11). Paired-end 2 x 100 bp Illumina reads from a 
metatranscriptomic investigation of bacterial vaginosis (BioProject accession number 
PRJEB21446) were retrieved from the Sequence Read Archive in October 2018 (12).  
5.5.2 In silico taxonomic analysis 
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We initially used pyANI (https://github.com/widdowquinn/pyani) to obtain pairwise ANI 
values with the mummer nucleotide alignment method on all 103 genomes obtained 
from the National Center for Biotechnology Information. Representative genomes for the 
14 different genomospecies were uploaded to JSpeciesWS in January 2019 and 
annotated with default conditions for the ANIb and Tetranucleotide frequency analysis 
(http://jspecies.ribohost.com/jspeciesws/#home) (13, 14). The same 14 genomes were 
uploaded to the ANI matrix software from the Kostas lab (http://enve-
omics.ce.gatech.edu/g-matrix/index). The faa file from prokka, containing protein 
sequences for identified open reading frames, were uploaded to the Kostas lab 
(average amino acid identity) AAI matrix software in January 2019 (14). For the 
purposes of our investigation, to create genomospecies bins for downstream analysis 
we adopted a conservative consensus approach. Thereby, if two or more of the tools 
indicated that the genomes represent the same genomospecies, we then counted them 
as the same genomospecies. 
5.5.3 Core-genome analysis 
Roary was used to cluster the open reading frames in the Gardnerella cohort to identify 
the core-genome and accessory-genome at 70% identity (15). The 200 core-genes 
were aligned using PRANK (16). The core-genome alignment was converted into an 
approximate maximum likelihood tree with FastTree and lineages were identified using 
BAPS within FastGear (17-19). The newick file from FastTree was viewed as a midpoint 
rooted tree in iTOL with bootstrap support values as branch labels (20). To construct the 




5.5.4 Accessory genome analysis 
The gene presence/absence file constructed by Roary were removed of core genes and 
analyzed for principal components in RStudio using prcomp (22). The elucidated 
genomospecies were overlaid onto the genomes. To identify genes responsible for the 
distinct clustering pattern observed, we used Scoary to identify genes in the Roary pan-
genome that are strongly associated with the 9 different genomospecies (23). The 
presence/absence matrix for genes annotated as sialidases, glycoside hydrolases, 
ATP-binding import proteins, or allantoin utilization were viewed as a binary matrix in 
iToL. Counts for the number of these genes within the different genomospecies were 
computed and viewed in Prism V8. 
5.5.5 Cluster of orthologous groups (COGs) and gene of interest quantification 
We uploaded the pan-genome reference file from Roary, which contains a 
representative gene for the 7,402 genes in the pan-genome database to EggNOG 4.5.1 
in November 2018 to identify functional categories for all possible genes (24). 
Normalized COG counts for each genomospecies were determined by dividing the 
number of genes for each individual COG annotation by the total number of genes that 
had any COG assigned. To identify all the genes with putative role in carbohydrate 
metabolism, we uploaded the pan-genome reference file from Roary to dbCAN which 
uses HMMER and DIAMOND to compare our query with the CAZy database (25).  
5.5.6 Taxonomic metatranscriptome analysis 
To determine the presence of the Gardnerella genomospecies within the 
metatranscriptome samples, we used the short-read classification program Centrifuge 
(26). Initially, we made a custom database by assigning the 5,971 total contigs from the 
147 
 
downloaded fasta files within the Gardnerella cohort to a specific genomospecies using 
our previously described conservative consensus approach. Therefore, our database 
contained all open reading frames and intergenic regions. Our classification scheme 
was designed to ignore the other members of the vaginal microbiota, so each read 
could be assigned as mapping to one or more of the Gardnerella genomospecies, 
mapping uniquely to just one genomospecies, or not mapping to any of the 
genomospecies. For the 20 samples used in our investigation we then computed the 
percentage of Gardnerella specific reads that uniquely mapped to an individual 
genomospecies by quantifying the number of unique reads per genomospecies divided 
by the total sum of unique reads that mapped to all genomospecies. The percentage 
matrix created by this analysis was hierarchically clustered using SciPy and viewed as a 
clustermap in seaborn. Additionally, the percentage values were viewed as a stacked 
barplot in matplotlib.  
5.5.7 Metatranscriptome functional analysis 
We built a pan-genome database in PanPhlAn using the presence/absence matrix 
previously identified by Roary (panphlan_pangenome_generation.py) (27). We mapped 
the Gardnerella specific transcriptome reads and quantified the coverage amount of 
every gene in the pan-genome for each metatranscriptome sample 
(http://panphlan_map.py). We used the mean coverage value for each gene across the 
twenty metatranscriptome samples. The top 224 expressed genes, defined as the mean 
plus standard deviation of the coverage level, were analyzed to identify any enriched 
COGs. To determine if the COGs were enriched within the metatranscriptome datasets, 




(Number of top expressed genes with COGX/Number of top expressed genes with a 
COG)/ (Number of total genes with COGX/Number of total genes with a COG) 
 
If the index was >1 then it indicated that COG was enriched within the top expressed 
genes. Additionally, we used a quantitative assessment of coverage values to identify 
genes within the Gardnerella pan-genome that were expressed at a statistically 
meaningful percentage within the dataset. To accomplish this, we viewed each 
individual gene in the pan-genome by plotting on the X-axis the number of isolates that 
harbor the gene identified by Roary and on the Y-axis the mean coverage value from 
PanPhlAn analysis of the 20 metatranscriptome samples. 
5.5.8 Statistical Analysis 
ANOVA for number of sialidase, glycoside hydrolase, ATP-binding import proteins, 
allantoin utilization genes, and CAZy database hits in the different genomospecies were 
performed in GraphPad Prism V8. Paired student T-test between select groups were 
performed in GraphPad Prism V8. Permutational multivariate analysis of variance 
(PERMANOVA) was performed on the gene_presence_absence_matrix from Roary in 
RStudio using the adonis2 command from the Vegan (https://cran.r-
project.org/web/packages/vegan/vegan.pdf) package.  
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Chapter 6: Phenotypic and genotypic characterization of linezolid-resistant 
Enterococcus faecium from the USA and Pakistan 
6.1 Abstract 
Linezolid is an important therapeutic option for the treatment of infections caused by 
vancomycin-resistant Enterococcus. Linezolid is a synthetic antimicrobial and resistance 
to this antimicrobial agent remains relatively rare. As a result, data on the comparative 
genomics of linezolid resistance determinants in Enteroccocus faecium is relatively 
sparse. To address this knowledge gap in E. faecium, we deployed phenotypic antibiotic 
susceptibility testing and Illumina whole-genome on hospital surface (environmental) 
and clinical isolates from the United States and Pakistan. We found complete 
concordance between isolate source country and mechanism of linezolid resistance, 
with all the United States isolates possessing a 23S rRNA gene mutation and the 
Pakistan isolates harboring 2-3 acquired antibiotic resistance genes. These resistance 
genes include the recently elucidated efflux pumps optrA and poxtA and a novel cfr-like 
variant. Although there was no difference in the linezolid MIC between the United States 
and Pakistan isolates, there was a significant difference in the geometric mean of the 
MIC between the Pakistan isolates that had two versus three of the acquired antibiotic 
resistance genes. In five of the Pakistan E. faecium that possessed all three of the 
resistance genes, we found no difference in the local genetic context of poxtA and the 
cfr-like gene, but we identified different genetic contexts surrounding optrA. These 
results demonstrate that E. faecium from different geographical regions employ 




Enterococcus faecium is a common gut commensal organism and an increasingly 
important cause of nosocomial infection.(1) One feature implicated in the success of E. 
faecium as a pathogen is its repertoire of acquired antibiotic resistance genes (ARGs) 
that enable evasion of antimicrobial therapy.(1) As an example, treatment of E. faecium 
infections with vancomycin has facilitated proliferation of the vanA gene cassette 
throughout E. faecium.(2) Due to the increase in vancomycin resistant Gram-positive 
pathogens, newer therapeutics, notably the oxazolidinones linezolid and tedizolid, have 
become important therapeutic agents for treating infections caused by this organism.(3) 
Accordingly, sporadic resistance to linezolid has been identified in cohorts of E. faecium 
and other Gram-positive bacteria.(4-6) These include vertically transmitted mutations in 
the linezolid target, the 23s rRNA gene sequence, and alterations in the ribosomal 
proteins L3, L4, and L22.(7-9) Acquired plasmid-borne antimicrobial resistance genes 
(ARGs), including the 23S rRNA methyltransferases cfr and cfr(B), have been 
previously identified in E. faecium.(10-12) Newly identified efflux pump genes, optrA and 
poxtA, have also been described in E. faecium.(13, 14)  
Despite the identification of vertically and horizontally transferable linezolid resistance 
determinants, a comprehensive genomic survey of linezolid resistant E. faecium isolates 
has not been performed. Additionally, there is a gap in knowledge on the relationship of 
established linezolid resistance determinants and their encoded phenotypic 
susceptibility to the newest oxazolidinone, tedizolid. To address this, we performed 
whole-genome sequencing and comparative analysis on 41 newly sequenced isolates 
from the United States and 8 newly sequenced isolates from Pakistan. To increase the 
number of isolates for analysis, we supplemented these data with 52 publicly available 
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genomes of E. faecium isolated from the same locations in the US and Pakistan. Our 
results indicate that the mechanism of linezolid resistance is more strongly associated 
with geography rather than E. faecium clade/phylogeny in this cohort, with resistant 
isolates from the US harboring the G2576T SNP in 23S rRNA loci and resistant isolates 
from Pakistan encoding combinations of poxtA, optrA, and a cfr-like ARGs.  
6.3 Results 
6.3.1 Acquired linezolid resistance genes (optrA, poxtA, and cfr-like) were found 





We accessed banked environmental and clinical isolates of 
linezolid non-susceptible E. faecium isolates from the 
United States and Pakistan as well as several known 
linezolid susceptible isolates from both locations to perform 
a genomic analysis of linezolid resistance determinants. 
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Figure 6.3.1 Recombination-free 
phylogenetic tree including 
MLST, country, source, 
resistance, resistance gene and 
mutation data. 
 Linezolid resistance in US isolates 
was attributed solely to the 
G2576T mutation of the 23S rRNA 
gene sequence. In contrast, 
linezolid resistance in Pakistan 
isolates resulted from different 
combinations of the acquired 
resistance genes optrA, poxtA and 
a cfr-like gene. Vancomycin 
resistance was observed in 90.6% 
(87/96) of the isolates and 
dalbavancin resistance was 
observed in 88.5% (85/96). 
Daptomycin resistance was 
observed in 3.13% (3/96) of the 
isolates with an additional 68.8% 




Pakistan. We used Kirby-Bauer disk diffusion and gradient diffusion methods in 
conjunction with CLSI interpretive guidelines to assign phenotypic resistance criteria to 
linezolid (resistant, intermediate, or susceptible) and tedizolid (using Enteroccocus 
faecalis breakpoints for non-susceptible or susceptible). Initially, we constructed a core-
genome phylogenetic tree on the 1691 core-genes between all genomes. Phylogenetic 
comparison of the cohort to reference isolates from E. faecium clades A1, A2, and B, 
determined that all isolates in the cohort belong to Clades A1 and A2, characteristic of 
human pathogens.(15) To gain further resolution on the relatedness of the E. faecium 
isolates, we excluded the Clade B isolate E1007 and constructed a recombination-free 
phylogenetic tree using parSNP (Figure 6.3.1). The phylogeny of the isolates was 
generally geographically stratified, as 80.4% (33/41) E. faecium from the United States 
were in Clade A1 and 90.9% (50/55) E. faecium from Pakistan were in Clade A2. The 
isolate cohort represented eleven identifiable multi-locus sequence types. 70.7% 
(29/41) of the US isolates were resistant to linezolid and of these, 100% (29/29) were 
positive for the G2576T 23S rRNA SNP using bowtie2 alignment of Illumina reads to the 
Aus0004 reference sequence (Figure 6.3.1).(16) A comparable amount of the E. 
faecium isolates from Pakistan, 72.7% (40/55), were also resistant to linezolid, however 
in contrast 97.5% (39/40) of these isolates were positive for an acquired linezolid 
resistance gene identified by ResFinder or prokka but negative for the G2576T SNP. 
The canonical 23S rRNA-methyltransferase, cfr, was not identified in our isolates, 
however a variant of the cfr family was annotated by prokka in 76.4% (42/55) E. faecium 
isolates from Pakistan (Figure 6.3.1). BLASTP query and comparison to previously 
characterized sequences of the cfr gene, the cfr(B) variant, and the ancestral rlmN gene 
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determined that the cfr-like gene shared 64% identify over 95% of query length with the 
original cfr gene and 65% identity over 97% of the length of cfr(B). An identity of 74.9% 
over 99.7% was previously used to classify cfr(B) as unique from cfr, therefore the gene 
we have described fits within the category of other emerging cfr-like family 
members.(17, 18) 78.2% (43/55) and 61.8% (34/55) of the isolates from Pakistan 
contained the linezolid ABC transporters poxtA and optrA, respectively. 76.7% (33/43) 
of the isolates with gene-based resistance harbored all three of the resistance genes 
identified in the cohort. 20.9% (9/43) of the isolates harbored only poxtA and the cfr-like 
gene, and 2.32% (1/43) harbored only optrA and poxtA. 90.6% (87/96) and 88.5% 
(85/96) of the isolates were resistant to vancomycin and dalbavancin respectively. Only 
3.12% (3/96) isolates were non-susceptible to daptomycin, another therapeutic 
commonly used to treat VRE in the US, however, an additional 68.8% (66/96) were 
tested to have minimum inhibitory concentration values in the susceptible-dose 
dependent classification range. These results indicate that while clade A1 and clade A2 
E. faecium isolates can be found in both the United States and Pakistan, there is a 
differential burden in the mechanism of linezolid resistance between the surveyed 
isolates from these locations.  
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6.3.2 Linezolid resistance differs by genes present, not by mechanism.  
The geometric mean MIC for linezolid (21.83 mg/L) was greater than the geometric 
mean MIC for tedizolid (2.87 mg/L) (Figure 6.3.2ab). There was minimal difference 
between the geometric mean MIC of isolates with gene-based resistance (40.75 mg/L) 
and isolates with mutation-based resistance (40.32 mg/L) (Figure 6.3.2c). However, the 
geometric mean MIC of isolates with all three observed resistance genes (64 mg/L) was 
Figure 6.3.2. Linezolid and tedizolid MICs and comparisons by basis of resistance mechanism.  
The geometric mean MIC of linezolid (a) is higher than the geometric mean MIC of tedizolid (b) at 21.83 and 
2.87 mg/L, respectively. There was no difference in linezolid resistance between isolates with gene- or 
mutation-based resistance mechanisms (c). However, isolates that harboured poxtA and cfr-like genes had 
significantly lower levels of linezolid resistance than those that harboured all three linezolid resistance 
genes (d); statistical analysis was done using the unpaired t-test in Prism v8. Please note, y-axis values for all 
graphs are log2 scaled for visual acuity. 
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significantly greater (P <.0001) than the geometric mean MIC of isolates that harbored 
only poxtA and the cfr-like gene (6.86 mg/L) (Figure 6.3.2d). Our results demonstrate 
that while tedizolid resistance and linezolid resistance may be related, there are several 
instances in our cohort where they are independent of one another. 22.9% (22/96) of 
the isolates were neither susceptible to both antibiotics nor resistant to linezolid and 
non-susceptible to tedizolid. Of these, 40.9% (9/22) of isolates had intermediate 
linezolid resistance but were susceptible to tedizolid, 36.4% (8/22) of isolates were 
linezolid intermediate and non-susceptible to tedizolid, and 22.7% (5/22) were 
susceptible to linezolid but non-susceptible to tedizolid. The previously identified 23S 
rRNA G2505A linezolid resistance mutation was not identified within the isolates from 
our cohort.(16, 19) However, heterogeneity at site 1232 in the aligned 23S rRNA gene 
of E. faecium Aus0004 was observed in all isolates from our cohort (with >17% 
frequency in 76 isolates). This site has not previously been associated with linezolid 
resistance and the mutation was observed in both linezolid resistant and susceptible 
isolates, therefore it likely does not contribute to phenotypic linezolid resistance. Within 
the population of E. faecium that contained the G2576T mutation at >17%, there was 
not a correlation between frequency of the G2576T SNP and phenotypic linezolid 
resistance.  





We used EasyFig to analyze the genetic context of optrA, poxtA, and the cfr-like gene in 
five isolates that harbored all three genes (Figure 6.3.3). The visualized genetic context 
of optrA was identical in Pakistan isolates EF_48, EF_111, and EF_181, as well as 
partially in EF_325. These segments harbored a fexA phenicol resistance gene 
adjacent to optrA. The context of optrA in EF_155 differed from the others and 
contained the ermA1 methyltransferase gene. The optrA contigs also contained several 
transposase-associated and phage-associated transposase genes, which could enable 
horizontal transfer of the optrA gene. The contig from EF_103 contained only the optrA 
Figure 6.3.3. Genetic context of optrA in isolates that harbour optrA, cfr-like and poxtA genes.  
In isolates EF_325, EF_048, EF_111 and EF_181, optrA is downstream of the resistance gene fexA and in isolate 
EF_155 it is upstream of an erm(A1) resistance gene. These contexts are similar to those that optrA was in when it 
was first identified. However, the mobile elements surrounding optrA in our isolates differ from those previously 
identified. optrA’s location near mobile elements may allow it to be transferable. 
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gene. In all cases poxtA was assembled on a short contig with no other flanking genes, 
and the genetic context around the cfr-like gene was identical in the isolates we 
observed. 
6.4 Discussion 
The molecular epidemiology of linezolid resistance in VRE is largely uncharacterized, 
but linezolid resistance is rapidly increasing.(5) Consistent with earlier reports on the 
distribution of isolates in E. faecium clades, all of our isolates were in the A1 or A2 
group.(15) Nearly 72% (69/96) of the isolates in this study were linezolid resistant, with 
an additional 18% (17/96) having intermediate linezolid resistance. Additionally, 85% 
(82/96) of the isolates were non-susceptible to tedizolid, with much lower MIC values 
than observed for linezolid, as has been previously observed in linezolid resistant E. 
faecium from Germany.(20) In our cohort, linezolid resistance can be attributed to a 
combination of resistance genes or the G2576T mutation in the 23S rRNA gene. While 
the resistance mechanism differs between geographic locations – with resistance in the 
strains recovered from Pakistan containing gene-mediated resistance determinants and 
US isolates harboring 23S rRNA gene mutation(s), both groups displayed similar 
phenotypic MIC distributions. Possibly due to differences between short-read Illumina 
and longer-read Sanger sequencing, we did not observe a correlation between the MIC 
to linezolid and the proportion of the G2576T mutation 23S rRNA allele, as has been 
identified previously.(21) Limiting linezolid use may partly curtail the spread of 
resistance, as the G2576T resistance mutation can arise in pathogens due to prolonged 
drug exposure and the cfr, optrA, and poxtA resistance genes identified have historically 
been capable of horizontal transfer through situation on mobile genetic elements.(14, 
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22-24) Tedizolid holds promise for treatment of multidrug resistant infections.(25) 
However, we found that 100% (69/69) of linezolid resistant isolates were also non-
susceptible to tedizolid, and 47% (8/17) of linezolid intermediate isolates were tedizolid 
non-susceptible. Unexpectedly, 5 isolates were linezolid susceptible but tedizolid non-
susceptible, although the MIC distributions for these isolates were near the resistance 
breakpoint for both antimicrobials. The MIC breakpoints published by the Clinical and 
Laboratory Standards Institute for non-susceptibility to tedizolid are lower than for 
linezolid based on pharmacokinetic and pharmacodynamic properties.(26) Future 
investigations to examine tedizolid specific resistance determinants and suitable 
breakpoints specifically for E. faecium are warranted.(25)  
To the best of our knowledge, the cfr 23S rRNA methyltransferase family and the optrA 
and poxtA efflux pumps are the only known acquired ARGs against linezolid.(10, 13, 14) 
These genes can also confer resistance to other antibiotics, including chloramphenicol 
and clindamycin, complicating treatment options. cfr, cfr(b), cfr(c), and unnamed cfr-like 
genes have previously been identified in linezolid resistant strains of Staphylococcus 
aureus, Clostridium difficile (now Clostridioides difficle), Enterococcus spp., E. faecalis, 
and E. faecium.(10, 11, 27-30) Interestingly, these genes do not appear restricted to 
pathogens but can be found in a diverse number of Gram-positive species, indicating 
that multiple opportunities for horizontal gene transfer may arise.(18) Previously, cfr and 
its variants have been identified in isolates from countries including the US, Germany, 
Spain, Italy, China, France, Denmark, and the United Kingdom, but to the best of our 
knowledge this is the first report from Pakistan. In all isolates that we observed the cfr-
like gene, we also identified poxtA or both poxtA and optrA. Among isolates that only 
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harbored the cfr-like gene and poxtA, the geometric mean MIC (6.86 mg/L) was 
approximately ten times lower than that of those that harbored all three identified 
resistance genes (64 mg/L), with one of the two-gene isolates achieving only 
intermediate resistance. The genes optrA and cfr have previously been reported co-
localized on plasmids in hospital borne vancomycin resistant E. faecium(31). Upon its 
discovery, there was doubt as to whether cfr(B) granted the same resistance phenotype 
in Enterococcus as it does in Staphylococcus or if the cfr-like gene from C. difficile also 
confers antibiotic resistance.(11), (32) Additionally, a recent study using a mouse 
peritonitis model found that tedizolid underperformed linezolid and daptomycin in 
bacterial clearance of cfr(B) positive E. faecium.(33) Treatment of cfr(B)-positive E. 
faecium infection with linezolid garnered 86% survival in a mouse peritonitis model, 
despite presenting MICs that would suggest linezolid resistance.(33) Our data, coupled 
with these observations, suggests that the relative contribution of the cfr-like gene to 
phenotypic resistance may be less significant than that of other resistance genes and 
could be attributed to significant genotypic divergence from the canonical cfr gene. 
These phenotypic discrepancies may be exacerbated by synergistic effects occurring 
between the optrA and poxtA transporters and the cfr-like methyltransferase that are not 
occurring when poxtA and the cfr-like gene contribute to resistance in the absence of 
optrA. Therefore, while it is possible the cfr-like gene, poxtA, and optrA contribute 
equally to linezolid resistance, further investigation is necessary to determine their 
individual impacts on the observed resistance phenotypes.  
Notably optrA resided in different contexts within our isolates. Comparing the ARG 
genetic contexts of isolates randomly selected from different branches of the 
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phylogenetic tree, we found several isolates with contexts similar to those which optrA 
was originally identified in - having either the fexA phenicol exporter gene upstream of 
optrA or an ermA antibiotic resistance gene downstream of optrA (Figure 6.3.3).(23) 
However, the mobile elements identified in our isolates (several of which are phage-
associated) differed from those previously observed near optrA. Although the limitations 
of short read sequencing prevented us from obtaining longer genetic contexts of the 
poxtA and cfr-like genes, poxtA, optrA, and cfr variants have previously been observed 
near mobilizing elements, with the cfr variants and optrA residing on plasmids.(10, 11, 
14, 23) 
This study aimed to characterize the molecular epidemiology and investigate the 
differential burden of linezolid resistance mechanisms in E. faecium from two 
geographically distinct locations. We found that all US obtained isolates have the 23S 
rRNA G2576T mutation while isolates from Pakistan harbor combinations of a cfr-like 
gene, optrA, and poxtA. While geometric mean MIC values for these groups did not 
differ greatly (40.75 mg/L for gene-based resistance and 40.32 mg/L for mutation-based 
resistance), there was a difference between isolates that harbored poxtA and optrA 
compared to those isolates that had all 3 putative ARGs. Daptomycin is the 
antimicrobial agent evaluated in this study with the highest rate of susceptibility based 
on in vitro testing; 3.12% (3/96) isolates in this study are phenotypically susceptible, 
however, 68.8% (66/96) isolates are susceptible-dose dependent to daptomycin. Of 
note, daptomycin therapy is not a viable option for pulmonary infections, but 
Enterococcus spp. are very uncommon causes of pneumonia.(34, 35) Additionally, in 
the case of isolate EF_524, therapeutic options would be extremely limited as the 
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isolate is resistant to linezolid, tedizolid, vancomycin, dalbavancin, daptomycin, and 
ampicillin – the primary antibiotics available for Enterococcus infection treatment. In five 
isolates that harbored all three ARGs, optrA was observed in different genetic contexts, 
while the cfr-like gene and poxtA were observed in similar contexts or were assembled 
on contigs which were too short to identify flanking genes. The major limitation of this 
study is that by using Illumina sequencing, we are unable to resolve plasmid versus 
chromosomal segments. The use of long-read sequencing may further provide context 
for the genetic environment surrounding cfr, poxtA, and optrA in the isolates from 
Pakistan. Nevertheless, our results indicate that E. faecium isolates can use distinct 
genetic strategies to achieve comparable in vitro linezolid resistance. Continued 
investigation of linezolid resistance in E. faecium and antibiotic stewardship of linezolid 
are advised to prevent the spread of resistance against this last-resort antibiotic.  
6.5 Materials and Methods 
6.5.1 Linezolid non-susceptible E. faecium cohort  
To understand the genotypic mechanism for linezolid resistance in two different 
geographies, we analyzed a collection of banked linezolid intermediate and linezolid 
resistant E. faecium isolates recovered from cultures of environmental or clinical 
specimens between 2012-2018. Inclusion criteria include phenotypic resistance or 
intermediate resistance to linezolid using the ETest gradient diffusion assay 
(bioMerieux, Durham, NC). We accessed 44 banked linezolid non-susceptible 
environmental E. faecium and 3 linezolid susceptible isolates from 2015-2016 that were 
sequenced in a previous analysis (BioProject PRJNA497126) from longitudinal 
surveillance of hospital surfaces in Pakistan. We newly sequenced 4 linezolid non-
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susceptible and 4 linezolid susceptible isolates collected from a previous analysis of 
clinical isolates obtained in 2012-2013 from two hospitals in Pakistan.(36) We 
additionally accessed 30 clinical isolates of linezolid non-susceptible E. faecium banked 
from the Barnes-Jewish Hospital clinical microbiology laboratory from 2015-2018. 
Finally, we accessed 8 environmental linezolid non-susceptible and 3 linezolid 
susceptible E. faecium isolates obtained from environmental surfaces in Barnes-Jewish 
Hospital during 2017-2018. E. faecium Aus0004 (Clade A1 reference), E. faecium 
E2134 (Clade A2 reference), E. faecium E1007 (Clade B reference) were obtained from 
a previous genomic analysis of Enterococcus evolution.(15) The linezolid resistant 
isolate due to 23S rRNA G2576T mutation, E. faecium VRE1558, and linezolid resistant 
isolate due to a 23S rRNA G2505A mutation, E. faecium E1644, were also included in 
phylogenetic analysis.(19, 37) 
6.5.2 Illumina whole-genome sequencing and genomic analysis 
Stock cultures of the E. faecium sequenced in this investigation were recovered from 
freezer vials and streaked out onto blood agar (Hardy Diagnostics). ~10 colonies were 
suspended into 1 mL of nuclease free water. Genomic DNA was extracted using the 
QIAamp BiOstic Bacteremia DNA kit (Qiagen, Germantown, MD, USA). Genomic DNA 
was sequenced with Illumina whole-genome sequencing, producing short read 
sequences. Illumina adapter sequences were removed using Trimmomatic (version 
0.38), and sequence contamination was removed with DeconSeq (version 0.4.3).(38, 
39) The processed reads were assembled into contigs using SPAdes (version 
3.13.0).(40) Isolates sequenced in this paper, as well as previously sequences isolates 
(including outgroups E1007, Aus0004, and E2134 – used for clade identification, and 
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VRE1558 and E1644 – positive for 23S rRNA mutations G2576T and G2505A 
respectively), were annotated with Prokka (version 1.12).(41) MLST was also 
determined using BLAST similarity (https://github.com/tseemann/mlst). Core-genome 
analysis was performed with Roary (version 3.12.0) on the .gff files from prokka. The 
core-genome alignment with PRANK was converted to an approximate maximum-
likelihood tree in FastTree (version 2.1.9). After determination that all of the isolates 
were from Clades A1 or A2 we removed the Clade B genome from analysis and 
performed parSNP (version 1.2) on the fasta files of the isolates.(42) The newick file for 
both trees were viewed in iTOL.(43)  
6.5.3 Antibiotic susceptibility testing 
Pure cultures of isolates had phenotypic antibiotic resistance determined using Kirby 
Bauer disk diffusion assays and gradient diffusion (i.e. Etest) assays. Both assays were 
performed according to the manufacturers’ instructions. The results were interpreted 
using the CLSI M100 criteria for Enteroccoccus.(44) Linezolid (BD, Franklin Lakes, NJ, 
USA) and Vancomycin (Hardy Diagnostics, Santa Maria, CA) were tested using Kirby-
Bauer Disks. Strains were classified linezolid susceptible at or above 23 mm, 
intermediate at 21-22 mm, and resistant at or below 20 mm. Isolates were classified 
vancomycin susceptible at or above 17 mm, intermediate at 15-16 mm, and resistant at 
or below 14 mm. We additionally tested linezolid (bioMerieux), daptomycin (bioMerieux), 
dalbavancin (Liofilchem, Waltham, MA, USA), and tedizolid (Liofilchem) using 
quantitative gradient diffusion assay and interpreted the MIC value in accordance with 
2019 CLSI standards. Strains were classified linezolid susceptible at or below 2 mg/L, 
intermediate at 4 mg/L, and resistant at or above 8 mg/L. Strains were classified 
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daptomycin susceptible at or below 1 mg/L, susceptible dose-dependent at 2-4 mg/L, 
and resistant at or above 8 mg/L. Isolates were classified dalbavancin susceptible at or 
below 0.25 mg/L.(44) As there is currently an absence of E. faecium breakpoints for 
tedizolid, we used the E. faecalis breakpoint criteria for our cohort; strains were 
classified tedizolid susceptible at or below 0.5 mg/L and non-susceptible above 0.5 
mg/L. Statistical analysis performed in Figure 2d was done using the unpaired t-test in 
Prism v8. All interpretation of Etest MIC values were performed with clinical accuracy 
and read appropriately. Reported Etest MIC values were rounded up to the nearest 
doubling dilution.  
6.5.4 In silico oxazolidinone resistant determinant identification 
ResFinder annotation of known resistance genes was used to identify isolates that 
harbored optrA, poxtA, and VanX.(45) We used Roary to assemble the pan-genome of 
the isolates and found that a cfr-like gene had been annotated in the 
genes_presence_absence output of the program.(46) The gene sequence was 
compared to cfr and variant cfr(B) sequences using BLAST.(11, 47) 
Following published suggestions for determining linezolid resistance mutations, the 
reads of processed isolates were aligned using Bowtie2 to a reference 23S rRNA 
sequence of Aus0004.(16) The 23S rRNA sequence of Aus0004 (NCBI Reference 
Sequence: NR_103056.1) did not harbor any of the mutations associated with linezolid 
resistance. SNPs that did not match the Aus0004 reference sequence were identified 
using a custom python3 script. From this alignment, the site of the SNP that correlated 
to the G2576T mutation (using E. coli numbering) responsible for linezolid resistance 
was identified. Isolates found to be positive for the mutation by this method had the SNP 
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in at least 50% of reads. To identify all isolates that had the G2576T mutation at any 
frequency, a second script was run to extract isolates with a SNP at the respective site. 
All isolates having the mutation at a frequency of at least 17% of reads, which is 
regarded as the minimum frequency for phenotypic linezolid resistance, were 
considered to be resistant by ribosomal mutation.(16) Other published mutations 
responsible for linezolid resistance were sought out but not identified in any of the 
isolates; these included the G2505 23S rRNA gene mutation and mutations in the L3, 
L4, and L22 proteins.(19, 48, 49)  
6.5.5 Data availability: 
All genomes sequenced in this study have been uploaded to the NCBI WGS database 
associated with BioProject PRJNA517335.  
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 Chapter 7: Pleiotropic effects of pgsA2 mediated daptomycin resistance in 
Corynebacterium 
7.1 Abstract 
 Daptomycin is an important drug of last resort in the fight against Gram-positive 
multidrug resistant bacteria. Corynebacterium are a genus of bacteria commonly found 
as skin commensals but also can be human pathogens. It has been found that 
Corynebacterium striatum can gain high level daptomycin resistance through null 
mutations in the phosphatidylglycerol synthase gene pgsa2 leading to a complete 
reshuffling of the cell membrane with the notable absence of phosphatidylglycerol. 
However, the extent that this phenotype is able to occur across other Corynebacterium 
species and the effects that this development has on cellular physiology has not been 
explored. To address this gap in knowledge we curated a cohort of Corynebacterium 
isolates and phenotypically assayed their ability to develop daptomycin resistance 
before performing Illumina whole-genome sequencing. We then determined that a 
number of resistant-susceptible pairs had predicted alterations in pgsa2 and that this 
occurred in one of the better studies species (Corynebacterium striatum) as well as 
rarer causes of infection. We also found that some pairs did not have these mutations, 
positing that multiple routes to daptomycin resistance may occur for Corynebacterium. 
Among phenotypic differences between daptomycin resistant and susceptible isolates, 
we found a number of compounds that had great antibacterial efficacy against 
daptomycin resistant C. striatum compared to daptomycin susceptible isolates. We also 
found changes in the cellular proteome between the resistant and susceptible isolate, 
with notable downregulation of nitrate reductase and a necessary cofactor. Consistent 
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with this finding, we determined that the daptomycin resistant isolates have impaired 
anerobic growth relative to the susceptible. This work provides important information on 
the extend of daptomycin resistance across pathogenic Corynebacterium and on the 
effects that development has on changing bacterial physiology.  
7.1 Introduction 
Corynebacterium are a diverse genus of Gram-positive bacteria that include the 
industrial source of monosodium glutamate (Corynebacterium glutamicum) as well as 
human pathogens (including the causative agent of diptheria Corynebacterium 
diphtheriae) but are predominantly found as skim commensals(1). One emerging 
pathogenic Corynebacterium is Corynebacterium striatum(2, 3). Prior clinical dogma 
has taught that C. striatum is purely a skin commensal and if found in isolation during 
cultures is a likely contaminant, however several studies have determined that C. 
striatum can be attributed as the causative infectious agent for different maladies (2, 3). 
Problematically, C. striatum are often multidrug resistant due to a high burden of 
acquired antibiotic resistance genes(2, 3). Therefore, drugs of last resort such as 
daptomycin are often the favored treatment.  
 Daptomycin is a lipopeptide antibiotic that is effective against growing and inert 
Gram-positive bacteria(4). Upon binding to the cell membrane, the lipid tail intercalates 
within the outer leaflet and multiple daptomycin molecules oligomerize to produce a 
pore which causes loss of membrane integrity and a non-lytic form of bacteria death(4). 
However, there have been many case reports detailing the overnight development of 
high level daptomycin resistance in C. striatum(5-7). Mechanistic work has determined 
that this phenotype is due to loss of function mutations in phosphatidylglycerol synthase 
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enzyme (pgsA2) in the resistant compared to wildtype isolates(5-7). Mutations in this 
gene are believed to be responsible for a complete loss of phosphatidylglycerol (PG) 
from the cell membrane(5-7). In order to maintain barrier integrity, this loss of PG occurs 
with a commensurate increase in the levels of phosphatidylinositol (PI) and glucuronosyl 
diacylglycerol(5-7)l.  
 While this phenomenon has been studied in C. striatum, there is a gap in 
knowledge on the extent of non-striatum Corynebacterium to develop high level 
daptomycin resistance. Additionally, there is a gap in knowledge on the effects that this 
massive rearrangement of lipid metabolism has on other aspects of bacterial 
physiology.  To address this gap in knowledge we assembled a cohort of clinical 
Corynebacterium isolates from a variety of species and assed if they were capable of 
developing overnight daptomycin resistance and then performing Illumina whole-
genome sequencing. We additionally performed proteomics and follow up experiments 




7.3.1 In silico species identification 
We initially wanted to investigate if there was a phylogenetic signal for predictive ability 
of daptomycin resistant development and so we performed average nucleotide identity 
analysis on the assembled cohort of sequenced bacteria, type genomes from NCBI, and 
known C. striatum genomes. Initial MALDI-TOF MS  analysis indicated that our cohort 
contained 23 different species, however ANI analysis was able to determine that only 16 
of those had ANI >96% with type strains. Additionally, we found that the remaining 
isolates represented 19 novel genomospecies. 4/16 of the recognized species and 7/19 
of the genomospecies had representative isolates that could develop high level 
daptomycin resistance.  
7.3.2 Resistant mutation 
mapping 
We used bowtie2 to align 
the reads from the resistant 
pairs to their respective 
susceptible genomes to 
identify genes that have 
SNPs. Similarly, we 
analyzed the protein amino 
acid sequence of the 
PgsA2 sequence in the 
resistant isolates to identify 
amino acid changes or  
Figure 7.3.1 ANI heatmap for entire cohort. Dark green blocks 
indicate isolates of the same species, the large number of 
singletons highlight the diversity of Corynebacterium. Upper 









































































































































truncations. 13/31 had identified amino acid changes and polymorphisms in the 
nucleotide sequence, 5/31 has SNPs in pgsa2 but no amino acid changes, and 7/31 
had changes in amino  


























































































Table 7.3. 1 SNP analysis of susceptible-resistant pairs. Table courtesy of Kate Wardenburg.    
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nucleotide and amino acid sequence but it could possible be to development of 
heteroresistant populations in our sample being unable to be resolved by de-novo 
assembly. 6/31 did not have any amino acid or nucleotide changes in pgsa2 which 
could indicate that Corynebacterium may have non pgsa2 mediated mechanisms of 
resistance.  
7.3.3 BiOLOG Chemical Sensitivity Screen 






Out of use for 
treatment of muscle 
pain and muscle 
control in 
Parkinson's patients  
Dichlofluanid 











susceptibility against PR and IR compared to PS, indicating that they may be agents 




for neuropsychiatric disorders. 2/6 of the compounds had known antimicrobial activity 
but dichlofluanid is a fungicide rather than an antibiotic. There is structural similarity 
between 5/6 of the compounds as all but alexidine contain bulky aromatic benzene 
rings. Alexidine contains long hydrocarbon stretches at it ends which could intercalate 
within a membrane.  
 
7.3.4 Proteomic identification of impaired nitrate reductase levels and anerobic 
growth assessment 
D,L-Propranolol 





Antiseptic used in 
mouthwash 
 
Table 7.3.2 Structure and description of top BiOLOG hits that had 
differential activity against daptomycin resistant C. striatum compared to 
susceptible. Table courtesy of Kate Wardenburg.    
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To assess global changes in gene 
expression as a result of pgsa2 
mutation we submitted triplicate 
cultures of the daptomycin susceptible 
C. striatum PS and its resistant 
isogenic clones PR and IR to the 
Washington University Proteomics 
core. Principal component analysis of 
the peptides indicate that protein 
expression profiles are similar within 
replicate but that each strain has a 
distinct pattern of expression from one 
another, including PR and IR. 
Figure 7.3.2 PCA of peptide fragments from 
proteomics. Analysis depicting that peptides 
clustered within sample and that there was a 
quantifiable difference between the susceptible 
versus resistant isolates but also between the 
two resistant isolates (PR and IR).  
Figure 7.3.3 Volcano plot of differential abundant proteins. Comparison of peptide fragments 
between IR and PS and PR and PS were used to identify genes that had significantly different 
abundance between these conditions.   
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Interestingly, PS and PR are remarkably similar on the 1st PCA axis compared to IR, 
indicating that a number of protein changes may be attributed to the in vitro culture 
growth of IR. PS and IR both differ from PS on PC2 but interestingly IR is closer to PS 
on that axis. More than half of the diversity between these sets is explain by PC1 and 
PC2. Differential expression analysis was performed to identify significant protein 
differences between PS-PR and PS-IR. We then investigated the common proteins that 
are similarity downregulated or upregulated in these two comparisons. 20 proteins were 
commonly downregulated and 3 were upregulated  
Gene Prokka Annotation COG Function 
Cor_064_00395 Fimbrial subunit 
type 1 
M cell wall anchor domain protein 
Cor_064_00397 hypothetical protein n/a n/a 
Cor_064_00398 hypothetical protein M Cna protein B-type domain 
Cor_064_00457 hypothetical protein C phosphate acetyltransferase 









Cor_064_01024 Bifunctional protein 
PyrR 
F Also displays a weak uracil 
phosphoribosyltransferase activity which 
is not physiologically significant (By 
similarity) 
Cor_064_01026 Dihydroorotase F dihydroorotase 
Cor_064_01090 hypothetical protein S n/a 
Cor_064_01210 Proton/glutamate-
aspartate symporter 
C sodium dicarboxylate symporter 
Cor_064_01245 hypothetical protein S Protein of unknown function (DUF3117) 
Cor_064_01277 Urocanate 
hydratase 
E urocanate hydratase (EC 4.2.1.49) 
Cor_064_01295 hypothetical protein n/a n/a 
Cor_064_01759 Nitrate reductase 
alpha subunit 
C nitrate reductase, alpha subunit 
195 
 
Cor_064_01760 Respiratory nitrate 
reductase 2 beta 
chain 
C nitrate reductase beta 
Cor_064_01767 hypothetical protein P ABC transporter, periplasmic molybdate-
binding protein 




E glutamine synthetase 
Cor_064_02220 hypothetical protein J UPF0176 protein 
 
Gene Prokka Annotation COG Function 




Cor_064_01517 Zinc import ATP-binding protein 
ZnuC 
P ABC transporter 
Cor_064_02052 hypothetical protein P ABC transporter 
 
After delving deeper into the individual proteins that were downregulated by function, we 
learned that the metal ion moybdate is used to create a protein cofactor molybdopterin, 
which is a necessary cofactor for nitrate reductase activity, therefore linking 
Cor_064_01767, Cor_064_00901, Cor_064_01759, and Cor_064_01760 together. We 
hypothesized that due to the membrane restructuring during daptomycin resistance 
development these protein products are unable to properly localize to the membrane 
and are therefore degraded. Given that nitrate reductase is important for anerobic 
growth, we did a semiquantitative growth assay by doing a 4 quadrant streak of PS, PR, 
Table 7.3.4  Proteins that are commonly upregulated in PR and IR when compared against PS. 




and IR, and then growing for 4 days. We found that PS grow up to the 4th quadrant and 
had lawns in quadrants 1-3 where as PR and IR only had single colonies in the 1st 
quadrant. We were going to do a more quantitative growth assay before being rudely 
interrupted by the SARS-2 novel coronavirus.  
 
7.4 Discussion 
Given the importance of daptomycin as a therapeutic of last resort and the 
growing incidence of Corynebacterium attributed infections, the rapid development of 
antibiotic resistance capable by this pathogen is alarming. Previous efforts from the 
Dantas Lab and others have determined that in Corynebacterium striatum, the 
mechanism of phenotypic resistance is due to null mutations in pgsa2 preventing 
presence of PG in the cell membrane. It is been demonstrated that some Enterococcus 
faecium and Enterococcus faecalis isolates are also capable of completely losing PG to 
gain daptomycin resistance, however a number of susceptible-resistant pairs did not do 
this- indicating that other mechanisms of resistance may occur(8). This gives strength to 
Figure 7.3.4  Four quadrant streak of PS (a), PR (b), and IR (c) under anerobic conditions after 
96 hours. Semiquantitative streaking depicts impaired growth for PR and IR as they are only 
able to grow single colonies in the first quadrant while PS can grow lawns in quadrants 1-3 and 
single colonies in quadrant 4.  
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our observation that a number of our Corynebacterium susceptible-resistant pairs do not 
have mutations in pgsa2 allele. A diverse number of mutations have been identified in 
Staphylococcus and Streptococcus which lead can lead to different outcomes such as 
alterations in cell charge and thickening of cell wall to cause daptomycin resistance(9, 
10). Further work is therefore warranted to investigate these possible mechanism of 
resistance in isolates without pgsa2 mutations and also performing lipidomic analysis 
across the cohort to examine true presence of PG.  
In addition to analyzing the mechanism of daptomycin resistance across this set 
of Corynebacterium species, we were also interested in more in depth analysis of the 
consequences of daptomycin resistance development in C. striatum. From a BiOLOG 
phenotypic microarray we were able to identify several compounds that had increased 
efficacy at preventing two daptomycin resistant strains (PR and IR) grow in rich media 
relative to an isogenic daptomycin sensitive strain (PS). Given the bulky aromatic 
moieties on 5/6 and the long hydrophobic chains of alexidine, it is possible that these 
compounds are able to more efficiently perturbate membrane integrity of C. striatum as 
it becomes daptomycin resistance and sheds PG. For enterococcus, it was determined 
that the loss of PG comes with a large decrease in membrane fluidity. In S. aureus, it 
was demonstrated that resistance to daptomycin can also increase resistance to other 
membrane intercalating agents, suggesting that alterations in phenotype may be 
species or mechanism of action specific(11). We did not see any increased resistance 
to the other cell envelope targeting antibiotics vancomycin or telavancin in our cohort. 
To the best of our knowledge there has only been one study analyzing global changes 
in microbial biology between daptomycin sensitive and resistant isolates but this was in 
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S. aureus. Interestingly, while we see similar changes in the cluster of orthologous 
group represented but not in the respective gene identities. One of our most interesting 
observations that genes involved in nitrate reductase and production of molybdenum 
were absent in the daptomycin resistance strains was not observed for S. aureus. The 
interpro page for nitrate reductase complex 
(https://www.ebi.ac.uk/interpro/entry/InterPro/IPR006468/) indicates that there is a direct 
interaction between the complex and PG. Further work is therefore warranted to 
validate our observation that the daptomycin resistant isolates have a growth defect 
when grown anaerobically. Given the limitation of oxygen in different body sites this may 
also mean that resistant C. striatum isolates have growth defects in certain infection 
niches.  
7.5 Materials & Methods 
7.5.1 Clinical and computational cohort 
We constructed a cohort of 198 clinical Corynebacterium isolates from patient samples 
obtained at Barnes-Jewish Hospital at Washington University in St. Louis, NorthShore 
at Northwestern, and Weill Cornell hospitals. To assay for daptomycin resistance 
evolution, 5mL tryptic soy broth (TSB) was inoculated with the wildtype isolate at .5 
McFarland standard and a daptomycin Etest strip was cut in half and placed in the 
inoculum. The inoculum was incubated at 35°C for 24 to 48 hours, at which timepoints 
the media was checked for turbidity. Media with suspected growth was used as 
inoculum and streaked onto a blood agar plate to grow the resistant isolate. Phenotypic 
resistance was tested using a daptomycin Etest gradient diffusion strip.  
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Genomic DNA was isolated using bacteremia kit (Qiagen) and converted into 
Illumina sequencing libraries with the nextera protocol(12). Samples were pooled and 
sequenced on an Illumina NextSeq 2500 system. Reads were demultiplexed by 
barcode, had adapter content removed with trimmomatic, and had contaminating reads 
removed with deconseq(13, 14). Processed reads were assembled de novo using 
spades and had open reading frames annotated with prokka(15, 16). To confirm isolate 
species, we accessed publicly available NCBI type strain sequences of 86 recognized 
Corynebacterium species. To further classify the C. striatum isolates, we accessed 
publicly available sequences of 81 clinical C. striatum strains isolated in Beijing, China 
(17). 
Sequenced isolates, type strains, and additional C. striatum genomes had average 
nucleotide analysis performed using pyANI. Heatmap was clustered hierarchically using 
seaborn. Confirmed C. striatum isolates had pan-genome identified using roary and the 
core-genome was clustered with prank(18). Alignment file was converted into a newick 
tree using fasttree and viewed with itol(19). For all resistant pairs we used bowtie2 to 
map the reads from the resistant isolate to the susceptible isolate and identify SNPs.  
7.5.2 Proteomic characterization 
Frozen stocks of the original C. striatum patient sensitive (PS) isolate and its 
isogenic daptomycin evolved patient resistant (PR) and in vitro resistant (IR) were 
streaked out on blood agar plates and triplicate single colonies were grown up overnight 
in 2 mL TSB. 1:1000 dilution of the overnight culture was added to 50 mL of TSB and 
grown aerobically to .05 OD600 in mid log phase. The samples were spun down and 
supernatant was removed. The samples were given to the Proteomics Core Laboratory 
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at Washington University in St. Louis for analysis with tandem mass tag. Peptides were 
quantified and mapped to the proteome for differential expression analysis. Cluster of 
orthologous group identification was performed on the PS proteome with EggNog 
v5(20).  
7.5.3 BiOLOG chemical sensitivity assay 
Frozen stocks of PS, PR, and IR were steaked out on blood agar overnight and a 
suspension was made from colonies in the fourth quadrant in TSB. The bacteria were 
all normalized to .05 OD600 and had 200 uL added to each well of pre loaded BiOLOG 
plates (PM11C, PM12B, PM13B, PM14A, PM15B, PM16A, PM17A, PM18C, PM19, and 
PM20B). The loaded plates were grown overnight at 37 °C and the had OD600 
assayed. Relative growth differences for PR and IR compared to PS were used to 
identify compounds that had the greatest ability to disrupt growth of the strains.  
7.5.4 Anerobic growth 
Frozen stocks of PS, PR, and IR were steaked out on blood agar and placed in a 37 
°C incubator in anerobic chamber. Growth was monitored and the plates were removed 
after 4 days for picture assay.  
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Chapter 8: General Conclusions 
In my thesis work I have investigated bacteria from a diverse range of Gram-negative 
(including Proteus, Klebsiella, Acinetobacter) and Gram-positive bacteria (Gardnerella, 
Enterococcus, Corynebacterium). Unifying the diverse goals of each chapter is the utility 
of whole-genome sequencing for improved taxonomy, understanding of intra-species 
diversity, and analysis of genes relevant for human infection. When combined with 
experiments designed to test these functional consequences of microbial diversity, 
including co-culture assays, antibiotic susceptibility testing, mouse infection, and human 
cohorts we can learn more about bacterial pathogens.  
 The use of whole-genome sequencing for improved taxonomic resolution was a 
major component of Chapters 3, 4, and 5. In Chapter 3 I started with Klebsiella variicola, 
which was known to be genetically dissimilar to Klebsiella pneumoniae and Klebsiella 
quasipneumoniae, but that distinction had not filtered down to the clinical laboratories 
until this project. An updated MALDI-TOF MS database then showed that a sizeable 
portion of what had been historically been called K. pneumoniae was actually K. 
variicola. Importantly, we demonstrate that some of these K. variicola strains were 
capable of causing greater infections in mice compared to the canonical pathogen K. 
pneumoniae. In contrast to the targeted taxonomic analysis in chapter, in chapter 4 I 
analyzed a diverse set of Gram-negative and Gram-positive bacteria that were collected 
in the same hospital. We found that certain bacteria were reliably identified by the non 
whole-genome based method of MALDI-TOF MS (ie. Pseudomonas aeruginosa and 
Enterococcus faecium) but a number of bacteria were misidentified. This sheds light on 
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the observation that rarer pathogens or environmental organisms may not be reliably 
identified by MALDI-TOF MS. Finally, in chapter 5 we start with one single species, 
Gardnerella vaginalis, but based off of past literature expected to identify multiple 
species being erroneously called as one. Thankfully our in silico efforts paid off and we 
determined that G. vaginalis may be considered 9 species. Further work is required to 
determine the true context of this genus within the bifidobacteriaceae.  
 The use of whole-genome sequencing for analysis of genes relevant to human 
infection was a major component of Chapters 2, 6, and 7. In Chapter 2 we found that a 
case of unidentified carbapenem resistance could be attributed to the presence of 
blaIMP-27 in a Providencia rettgeri. We test the functional consequences of this gene by 
demonstrating that P. rettgeri PR-1 and an additional Proteus mirabilis isolate PM187 
are capable of conjugating resistance into E. coli J53. In chapter 6 we took advantage of 
the E. faecium isolates from Chapter 4 and added more isolates sequenced in the 
United States to study resistance to the critical antibiotic linezolid. Importantly, we found 
that the same phenotype of linezolid resistance can be attributed to two parallel but non 
overlapping mechanisms of resistance. In the United States cohort, all isolates had a 
G2576T SNP in their 23S rRNA loci, which has been demonstrated to prevent linezolid 
binding. In contrast, the Pakistan cohort all contained either 2 or 3 acquired ARGs. 
These ARGs represent two linezolid specific efflux pumps (optrA and poxtA) as well as 
a novel cfr methyltransferase variant. Even within the Pakistan cohort we found the 
functional consequences of ARG carriage as isolates with all 3 resistance genes had a 
significantly higher minimum inhibitory concentration against linezolid compared to 
isolates that only had 2 ARGS. Further worrisome is the greater potential for these 
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ARGs to pass amongst pathogenic strains. Finally, in Chapter 7 we analyzed the 
functional consequences of antibiotic resistance in Corynebacterium striatum isolates 
that evolve high level daptomycin resistance. We initially used WGS to determine that a 
number of these isolates may evolve resistance via non pgsa2 methods and then 
proteomics to determine that null mutations which confer pgsa2 resistance drastically 
alter the repertoire of proteins that are produced. Importantly, we found impairment in 
nitrate reductase and a necessary cofactor which could impair the daptomycin resistant 
C. striatum isolates at growing anaerobically.  We then tested that indeed the resistance 
strains were unable to grow as well as the susceptible strain under anerobic conditions.  
 
